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Abstract
Investigations were conducted to identify biomarkers o f exposure to dinitropyrenes 
(DNPs), which are mutagenic and carcinogenic residues o f incomplete combustion. One 
possible biomarker, a DNP-protoporphyrin EX adduct, was not found in analytically useful 
quantities in liver tissue or in bile. Clastogenicity, a biomarker o f effect, also was found 
to be absent in marrow cells following subchronic exposure o f rats to DNPs by gavage.
Solubility studies, used as a basis for dosing guidelines, revealed that DNPs are 
relatively insoluble in both aqueous and lipid tissue compartments. Calculated log P values 
indicated that the reduced metabolites o f DNPs probably are more soluble in tissues than 
are DNPs. Thus, increasing solubility may drive nitroreduction.
The dependence of expression of a DNP-related biomarker on nitroreductase 
activity led to efforts to quantify nitroreductase activity. A nitroreductase assay of hepatic 
cytosol surprisingly revealed that DNP nitroreduction proceeded according to log [FMN], 
as well as to enzyme content. Further experiments revealed that flavin-dependent 
nitroreduction occurred by chemical, rather than enzymatic activity. This reaction should 
have been unfavorable thermodynamically, and so electrochemical experiments were 
undertaken to re-measure the electrochemical half-wave reduction potential.
Cyclic voltammograms of 1,6-DNP, using a platinum working electrode, vs. 
Ag/AgCL, yielded a reduction wave with a crest at -100 mV. Electrolysis o f 1,6-DNP at 
potentials at least as positive as 0.00 mV vs. Ag/AgCl reference electrode, using platinum 
or mercury working electrodes, yielded l-amino-6-nitropyrene and pyrene-1,6-diamine, 
proving that the wave in cyclic voltammetry was a nitroreduction wave. Thus, DNPs are 
reduced more easily than previously reported.
viii
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Flavin-dependent nitroreduction has been studied extensively in certain nitroarene 
pharmaceuticals, and the nitroreduction mechanism is well understood. Extension o f this 
chemistry to DNPs reveals that the oxidative damage and protein alkylation that 
accompany the nitroreduction reaction may act as tumor promoters. Thus, direct exposure 
o f tissues to DNP nitroreduction may cause fixation o f more mutations than might 
be expected of exposure to DNP metabolites only. This mechanism may be important to 
consider relative to tumorigenesis and biomarker studies, and to DNP risk assessment.
ix
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Introduction
The characterization of DNA as the genetic code and the heritable nature o f some 
cancers have focused much attention of the concept that changes in the basic genetic code 
(mutations) could be involved in cancer induction. Confirmation of this concept has been 
obtained in two parallel lines o f research. In one, it has been found that mutations in 
normal cellular growth-regulatory genes can alter their expression, resulting in changes in 
mitosis and differentiation. Another line o f research has identified mutagenesis as a 
primary mechanism by which exposure to certain chemicals initiates development of 
cancer. Ongoing efforts have continued to expand knowledge of metabolic activation of 
chemicals, identify specific DNA targets, and characterize gene modifications and their 
biochemical consequences that are associated with tumor formation. The resultant pool 
o f information has begun to be tapped for insights into prevention and cure o f cancers.
Among organic chemicals, nitrated polycyclic aromatic hydrocarbons have 
received attention as potential carcinogens. Nitroarenes are formed in small quantity in 
combustion processes and atmospheric photochemical reactions (1.1-1.3). Combustion 
products that contain nitroarenes include exhausts from power plants, diesel engines, and 
indoor kerosene space heaters (1.4). Nitroarenes also have been identified in grilled 
chicken (1.5) and photocopier toners (1.6). Their occurrence in these matrices would 
assure human exposure to these potent bacterial mutagens (1.7) and carcinogens (1.8,1.9). 
Among the more well known members o f this class of compounds are 1,3-, 1,6-, and 1,8- 
dinitropyrene.
It is thought that the nitro group of nitroarenes is reduced stepwise through 
nitroso, and hydroxylamine intermediates to an amine through normal metabolic processes
1
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2(Figure 1.1). In most cases, the hydroxylamine and related derivatives appear to have the 
potential to act as ultimate carcinogens (1.10,1.11). An understanding o f the mechanisms 
of interaction of the hydroxylamine intermediate with DNA had already been achieved in 
research on arylamines, which give rise to hydroxylamines through A'-oxidation.
Much of the research on DNPs to date has been directed at elucidation of the 
mechanisms just described, yielding information on bacterial and mammalian metabolism,
o*,
nitro
T
2e
amineN-
Ac
DNA
nilroso
A c
N-acetoxyamine nitrenium
Figure 1.1 Nitroreduction pathway, showing the two-electron reduction steps, the O- 
acetylated intermediate, and the putative nitrenium ion. The nitrenium ion is common 
to nitroarene reduction and amine iV-oxidation, and is believed to be the ultimate 
carcinogen in reaction with DNA.
the DNA adduct profile, and oncogenes involved in mammalian tumor formation 
(1.12-1.20). More recently, investigations have been undertaken to identify biomarkers 
that would be useful in assessing the risks of environmental exposure to DNPs. These
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3have included adducts o f DNA gene mutations in lymphocytes (1.21); and adducts of 
heme in peripheral blood (1.22). Another recent line o f research has revealed that DNP 
metabolism and binding are affected by concurrent administration o f other compounds 
(1.18,1.23, 1.24). While justifiable attention has been focused on the consequences of 
human exposure to DNPs. the environmental consequences o f large-scale release o f DNP- 
containing exhausts into the atmosphere has not been properly evaluated.
The relative dearth of information about the consequences o f DNP release into the 
environment has led to its inclusion as a compound of special interest in a recent grant 
proposal on the effects of pollutant mixtures on local ecosystems (1.25). A specific focus 
of those studies was evaluation o f potential biomarkers o f exposure to DNPs, in the 
objective of developing a series o f assays that estimated DNP-specific genotoxicity in feral 
rodent populations obtained from polluted environments.
Previous studies in the literature generally have investigated the use o f DNA 
adducts, and more recently adducts o f peripheral blood protoporphyrin IX, as markers of 
exposure specific to DNPs. One hypothesis of the current studies was that protoporphyrin 
adducts could be detected most easily in the bile, an elimination pathway for porphyrins 
and their metabolites; or in liver tissue, where DNP nitroreductase activity is higher than 
in peripheral blood. Cytogenetic assays also have been used to evaluate clastogenic 
mechanisms in various classes o f compounds, but to date, no cytogenetic tests have been 
performed on mammalian tissues following in vivo exposure to DNPs. Therefore, it was 
hypothesized that cells exposed to DNPs in vivo would exhibit clastogenic changes 
consistent with the findings in cells following in vitro DNP exposure.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4Formation of these biomarkers was expected to be a function not only o f exposure, 
but also o f nitro reductive metabolism. This led to a decision to monitor both exposure 
levels and nitroreductase activity. A control reaction in the nitroreductase assay 
unexpectedly revealed spontaneous nitroreduction, which had not been described 
previously for DNPs, nor for any other nitro-polycyclic aromatic hydrocarbon. As the 
selection o f appropriate biomarkers and the proper interpretation o f their meaning 
depended on an accurate understanding of their metabolism, non-enzymatic DNP 
nitroreduction was characterized further, and is described in this work.
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Chapter 1 
Literature Review
Chemical structure and properties
8
+ o
N
Pyrene 1,3-DNP 1,6-DNP 1,8-DNP
Figure 1.1 Pyrene, showing numbers o f carbon positions. 1.3-. 1,6-, and 1,8- 
dinitropyrene are also shown. Other known isomers include 1-, 2-, and 4-nitropyrene.
1,3-, 1,6- and 1,8-Dinitropyrene (DNP) are symmetrical and planar tetracyclic 
aromatic hydrocarbons, with a nominal molecular weight o f 292 (Figure 1.1). The
nitro groups are oriented close to the plane of the parent molecule (1.1), with one 
calculated value of 28° out-of-plane (1.2). DNPs are moderately soluble in toluene and 
DMSO (1.3), and form light brown needles when recrystallized from benzene and 
methanol (1.4), but can also be isolated as an orange crystalline solid (1.3).
DNPs readily undergo chemical nitroreduction. The partially reduced 
intermediates, 1-nitro-X-nitrosopyrene and 1-amino-X-nitropyrene (X=3, 6, or 8) are 
sufficiently stable that they have been synthesized, but the hydroxylamine is apparently 
unstable (1.5). The electrochemical half-wave reduction potential for the initial DNP 
reduction step is reportedly -0.5V using a dropping mercury electrode, vs. saturated 
calomel electrode (1.6,1.7), and approximately the same for l-nitro-6-nitrosopyrene (1.7).
molecular volume of pyrene is 186 A3, and its approximate surface area is 213 A2. The
7
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8Ring-oxidation o f DNPs has not been identified in any biological studies, but has been 
demonstrated chemically under harsh conditions (1.8): reaction with superoxide anion 
radical yielded substitution o f a hydroxyl for a nitro group; while trifluoroperoxyacetic acid 
treatment caused conversion o f a k-region of DNPs to a lactone.
Environmental sources of nitro-PAH and DNPs
Nitroarenes are formed in natural and anthropogenic processes. The substrates for 
natural reactions include volatile and semivolatile components of natural sources as 
seepage from tar pits and rock formations (1.9), decomposition of organic sediments 
(1.10), and combustion processes such as forest fires (1.11). Anthropogenic sources 
include coal mining (1.12), coal liquefaction (1.13), oil drilling (1.14), and various 
combustion processes including trash incinerators (1.15), internal combustion engines 
(1.16-1.19), and coal furnaces (1.20, 1.21).
In combustion processes, fuel-rich or oxygen-starved conditions give rise to PAH 
through hydrocarbon radicals, including butadiene and acetylenic radicals (1.22). 
Butadiene radicals can coalesce with each other or with acetylenic species to form 
aromatic systems. If nitrogen oxides are present under these conditions, the newly formed 
PAH can become nitrated. Typical conditions favorable to formation o f nitrated PAH, 
including nitropyrenes (NP) and DNPs, are found in exhaust gases as they emerge from 
internal combustion engines, especially diesels (1.23-1.25); coal-fired power plants (1.20); 
steel mills (1.26); and barbecues (1.27); among others.
Nitration of pyrene can occur in polluted atmospheres in the presence of N 02 and 
sunlight, yielding 2-NP (1.28, 1.29). A dark nitration reaction between N20 5 and pyrene
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9also occurs, yielding mostly 4-NP (1.29), with lesser amounts o f 2-NP. These isomers are 
not found in combustion exhausts, where the sole mononitrated pyrene isomer is 1-NP 
(1.16, 1.30). The presence of all three isomers in most polluted air samples indicates that 
the pollutants were formed in both combustion and atmospheric reaction processes (1.28, 
1.31). Di-nitration has been demonstrated to occur in the laboratory, but the 
concentrations of substrates, and HN03 catalyst, were higher than occur in even the most 
polluted urban atmospheres (1.15, 1.32).
Respiratory exposure to NPs and DNPs occurs with exposure o f humans to 
polluted outdoor atmospheres. However, exhausts from indoor sources including 
unvented indoor kerosene heaters and liquefied petroleum heaters (1.33, 1.34), and 
tobacco smoke (1.35) contain nitro-PAH. Cooking processes, including grilling and 
smoking o f meats, have been found to lead to formation of NPs (1.27, 1.36-1.38) and 
DNPs (1.39).
Environmental fate
There is laboratory evidence that microbial activity causes degradation of low 
concentrations o f 1-NP and DNPs (1.40). Degradation activity was more rapid in the 
presence of greater numbers of colony forming units, and when microbes had been 
exposed to polluted environments previously. Higher concentrations of DNPs tended to 
inhibit degradation. Another decay pathway, photodegradation, causes DNP to 
decompose to a nitro-hydroxy compound at a rate tenfold higher in solution (0.5 da) than 
on solids (5 da). Both rates were more rapid than those observed for 3-nitrofluoranthene 
(1.41).
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Bacterial metabolism and mutagenesis
The Ames bacterial mutagenicity assay (1.42-1.44) has been used extensively with 
DNPs (1.45-1.49). The standard screening procedure without added enzymes yields an 
extreme positive mutagenic response in strain TA98, indicating that DNPs are frameshift 
mutagens in a reversion assay. DNPs are not active in base pair-substitution strains such 
as TA100. Amino nitropyrenes and diaminopyrenes are four orders o f  magnitude less 
mutagenic in this assay than DNPs (1.50-1.52).
Forward mutations in E. coli lacl operon have been identified as -1 frame shifts in 
G:C sequences; but in contrast to the Ames reversion assay, an equal number o f basepair 
substitutions were identified at G:C (1.53, 1.54). Oligonucleotide hybridization 
experiments also have revealed the presence o f large deletions (1.55). These began and 
terminated at sites which had considerable sequence homology, and often contained 
palindromic subsequences.
The DNA target o f the metabolically activated intermediates, A-hydroxylamino- 
or jV-acetoxyaminonitropyrenes, has been identified as C8-deoxyguanosine (1.53, 
1.55-1.58). The resultant adduct is A/-(deoxyguanosin-8-yl)-1 -amino-X-nitropyrene, 
where X  corresponds to the 3, 6, or 8-isomer. The vast majority o f these adducts appear 
to be repaired in wild-type bacteria (1.55).
Bacterial DNP metabolism has been examined in S. typhimurium bacterial strains 
TA98NR (1.59) and TA98/DNP6 (1.60). Strain TA98NR is a mutant strain o f TA98 that 
lacks the "classical" nitroreductase that reduces nitrofurans, 1-NP, and 1,3-DNP to 
mutagens; but it retains other nitroreductases which can reduce 1,6- and 1,8-DNP (1.61).
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TA98/DNP6 has a full complement o f nitroreductases, but lacks an acetyl coenzyme A- 
dependent acetylation enzyme (1.60, 1.62). Using these strains, it was found that the 
explanation for the very high mutagenicity of 1,8-DNP compared to 1-NP was associated 
not with a difference in nitroreduction, but with increased enzymatic acetylation o f N- 
hydroxyl-l-amino-8-nitropyrene as a substrate for N, O-acetyltransferase (1.52, 1.62). 
These findings were confirmed by product analysis (1.52). Thus, reactivity with bacterial 
DNA depends not only on the presence o f specific nitroreductases, but also on 
acetyltransferase activity toward the hydroxylamine intermediate.
Addition o f mammalian enzymes to the bacterial mutagenicity assays has yielded 
insights into mammalian DNP metabolism. Hepatic post-mitochondrial supernatants (S9 
fractions) reduced the mutagenicity of DNPs (1.63, 1.64). In contrast, they increased the 
mutagenic activity o f aminonitropyrenes ( 1.50, 1.65). The increase in amine mutagenicity 
occurred from N-acetylation, but not sulfation. Inhibition of DNP mutagenicity was more 
marked in assays utilizing S9 from rats pre-induced with Aroclor 1254 (1.66) than from 
un-induced rats. Inhibition was associated with S9 enzymatic activity, and with the 
accompanying phospholipid fraction. Microsomal enzymatic inhibition of mutagenicity 
was found to vary with the isomer and species: o f the three DNP isomers, 1,3-DNP was 
most easily inactivated by human cytochromes 3A4, whereas rat cytochromes 1A1 and 
1A2 were equally effective against all three DNP isomers (1.67).
Mammalian cell studies
Many similarities exist between bacterial and mammalian cell DNP metabolism. 
Metabolic activation appears to follow the same sequence as in bacteria, including
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requirements for nitroreduction and acetylation (1.68). As with bacteria, the initial 
nitroreduction step appears to be limiting (1.69, 1.70). The genotoxicity expressed in a 
given cell line tends to mirror the nitroreductase and acetyltransferase capabilities o f those 
cells (1.69, 1.71, 1.72).
The time o f exposure to DNPs that is required for expression of genotoxicity 
appears to be a function o f nitroreductase enzyme activity in each cell type. Mouse 
lymphoma cells developed mutations after an 18 hr exposure to DNPs, but not after a 30 
min exposure (1.73,1.74). Longer exposures were required for genotoxicity to be evident 
in V79 cells (1.75-1.77) and H4-II-E rat hepatoma cells (1.78), apparently in proportion 
to nitroreductase activity.
Some differences have been found between bacteria and mammalian cells with 
respect to DNP metabolism. Unlike bacteria, there is no formal mammalian 
nitroreductase; rather, nitroreductase activity is a composite function of many enzyme 
systems, each of which is recognized for some other primary function (1.67, 1.79-1.83). 
Cell cultures respond somewhat differently than bacteria to added S9. As with bacteria, 
S9 inhibited mutagenicity from 1,6- or 1,8-DNP. but in contrast to bacteria, small 
quantities of S9 actually caused a 15-fold increase in 1,3-DNP mutagenicity in a Chinese 
hamster ovary Hypoxanthine-Guanine Phosphoribosyl Transferase (HGPRT) assay (1.84).
There was generally a partial dose-response relationship between DNP 
concentration and mutation rate in cell cultures. Rat (1.85, 1.86), mouse (1.86) and 
human (1.85) hepatocytes, and V79 cells (1.77), all demonstrated dose-dependent 
increases in various genotoxicity indices upon exposure to concentrations of DNPs up to 
5 |iM. Beyond that leveL, the mutation rate frequently became less positive with increasing
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dose. This effect was most dramatic in yeast, where the highest doses were associated 
with a return of the mutation rate to near baseline levels (1.87). Less dramatic declines in 
genotoxic indices were noted in H4-II-E hepatoma cells (1.88), and normal human 
lymphocytes (1.89). Alveolar type II cells and Clara cells (1.90), and Chinese hamster 
lung (V79) cells (1.71, 1.91) demonstrated only a slight tendency for genotoxicity to 
decline, and mouse lymphoma L5178Y cell genotoxicity plateaued without a subsequent 
decline at 0.5 pg/mL (1.7 uM) (1.73, 1.74). No explanations were offered for this 
behavior, but it might be accounted for by nongenotoxic cytotoxicity. The only report 
along that line described lysis of erythrocytes or bacteria in the presence o f 1,6-DNP and 
light (1.92).
Oxygen was observed to strongly inhibit mutations in yeast following DNP 
exposure (1.87). Under room air. mutations were observed, and incubation under nitrogen 
caused a substantial increase in mutations. Unrelated studies with oxygen inhibition in 
cytosolic nitroreductase assays indicated that oxygen inhibited formation o f nitroreduced 
DNP products (1.63). The phenomenon o f oxygen inhibition of nitroreductase activity is 
well recognized (1.93).
The DNA damage by DNPs in eukaryotic cells has been characterized in a number 
of tests. The major DNA adduct (95+%) following exposure o f mammalian cells to DNPs 
is '(deoxyguanosin-8-yl)-l-amino-X-nitropyrene (1.69, 1.70), as in bacteria. The latter 
study contains a description of a minor adduct (5%), identified by 32P-post-labeling, co­
migrated with the adduct formed by incubation of poly(dA) with jV-hydroxyl-1 -amino-8- 
nitropyrene. Single-stranded DNA breaks have been found in primary mouse hepatocytes 
and rat H4-II-E hepatoma cells treated with DNPs (1.78).
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Cytogenetic damage attributable to DNP exposure in cell cultures consisted of 
gaps, breaks, fragments and interchanges (1.88, 1.89) in RL4 rat liver epithelial cells and 
freshly isolated human lymphocytes. Kinetochore-positive and kinetochore-negative 
micronuclei have been identified in different types of fibroblasts (1.76, 1.77). The 
kinetochore-positive micronuclei were consistent with another study on mitotic spindle 
morphology, which identified 1,6-DNP as a spindle poison (1.94).
As would be expected, a DNA repair response has been observed in cell cultures 
following exposure to DNPs. Unscheduled DNA synthesis (1.95) has been found in a 
number of cell types, including human bronchial and tracheal epithelium (1.96), primary 
human hepatocyte isolations (1.97), normal mammary epithelial cells (1.98), rabbit alveolar 
type II cells and clara cells (1.90), and rat and mouse liver cells (1.86). The repair 
appeared to be imperfect. For example, DNP-induced mutations in a viral plasmid vector 
consisted o f frameshifts and G:C -  T:A transversions at specific loci (1.99). Mutations 
in the HGPRT test and Thymidine Kinase test (1.69, 1.73, 1.100) tended to be frameshifts 
and basepair changes, whereas mutations in the ouabain locus (1.74) were base-pair 
substitutions.
Whole animal studies
Distribution and elimination o f 1 -NP and DNPs
The uptake and elimination of DNPs were investigated in one study (1.101). 
Intragastric administration of [JH]-1,8-DNP (0.25 mg/kg, 4.25 /xg per mouse) to groups 
of five or six female BALB/3 mice (body weight 17 g) yielded poor overall intestinal 
uptake. After nine days, fecal elimination accounted for about 45% of the total dose, 
while another 15% appeared in the urine, leaving retained residues at 170 ,ug per mouse.
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Most o f the elimination occurred within the first two days; by the third day, the daily 
elimination of DNP was less than 1 percent o f the dose.
Liver radiolabel increased to 3 % (127.5 ng/liver) of the total dose at 7 hr, then fell 
to 1% by 48 hr. Kidney and blood radioactivity were roughly tenfold lower than in the 
liver at all time points. No other non-intestinal tissues, including spleen and lung, 
developed significantly elevated DNP levels at any point in the study.
Segmental uptake experiments revealed that absorption did not occur in the 
stomach. Absorption from the large intestine was about half as efficient as in the small 
intestine, as measured by blood radioactivity levels. Even so, 81% of the administered 
dose still resided in the small intestinal lumen after 2 hr.
Other related studies were conducted with 1-NP, which can be oxidatively 
metabolized, and has different partitioning properties. For example (1.102), male F344 
rats were given radio labelled 1-NP by gavage at 100 mg/kg. After five days, fecal 
elimination accounted for 51% of the dose, and an additional 19% was eliminated in urine. 
Fecal metabolites included 1-aminopyrene (11.7%), 1 -amino-6-hydroxypyrene, and 1- 
amino-8-hydroxypyrene (4.6%). Unchanged 1-NP (6.6%) was also found in feces. Bile 
samples contained 1-aminopyrene, 1-NP and a number of their ring-hydroxylated 
derivatives, in unconjugated form and as glucuronide and sulfate conjugates. Total biliary 
metabolites accounted for about 5% o f the dose. Aminohydroxypyrenes and their 
conjugates were tentatively identified in urine; they amounted to 3% o f the total dose.
In a second study (1.103), 1-NP was administered to female F-344 rats orally at 
10 mg/kg. Elimination was measured as total drug and metabolites eliminated by a given 
route after seven days. In this case, 55% o f the administered dose was eliminated in urine,
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whereas 35% emerged in the feces. When the same amount o f NP was given 
intraperitoneally, the elimination products were similar, but 60% o f the dose was 
eliminated in urine, and 20% in feces. The metabolites were diverse polar species, none of 
which accounted for more than 10% of the dose. 1-Aminopyrene, iV-acetyl-1- 
aminopyrene and 1-NP were detected in amounts less than 1%. The oral dose was 
eliminated more rapidly than the intraperitoneal dose. Orally dosed animals eliminated 
approximately twice as much aminopyrene and ring-oxidized aminopyrenes as those dosed 
intraperitoneally. In both studies, nitroreduction was considered a major route of 
metabolism.
A comparison of results between the DNP study and the NP studies suggests that 
1-NP can be absorbed and metabolized much more readily than DNPs, as indicated by the 
quantities o f NP metabolites following the much larger NP doses. In the DNP study, 
dietary fiber may have restricted the absorption and metabolism of such a low dose of 
DNP (1.104-1.106). An alternative explanation for the difference in uptake and 
metabolism of DNPs compared to NPs may be that DNPs simply are much less soluble. 
Support for the latter suggestion can be found in studies where DNPs were found at the 
site o f injection months after the rats had received DNP doses o f 0.8-8 mg/rat (1.107, 
1.108). Repetition of the DNP study (1.101) using increased doses o f DNPs and 
controlling for dietary fiber would aid in the interpretation of this aspect o f the DNP 
studies.
Enzvme induction
Short-term dermal exposure to nitrated pyrene mixtures (composition not defined) 
induced both cutaneous and hepatic monooxygenases in neonatal rats (1.109). Aryl
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hydrocarbon hydroxylase, ethoxycoumarin O-deethylase and ethoxyresorufin O-deethylase 
activities were increased 2- to 10-fold over vehicle and vehicle-pyrene controls after 24 
hr. Epoxide hydrolase activity was unaffected. Total cytochrome P450 activity was not 
increased.
Table 1.1 lists the effects o f individual nitro- and DNPs on selected Phase I 
enzymes in young male Sprague-Dawley rats ( 1.110). The values are expressed as a ratio 
o f the enzyme activity induced by the nitrated compound to that of its parent PAH. In the 
case o f pyrene, minimal enzyme induction occurred. 1,8-DNP significantly increased 
activities o f aryl hydrocarbon hydroxylase, 7-ethoxycoumarin deethylase and aminopyrine 
N-demethylase. All NPs significantly elevated 1-NP reductase activity. Another 
experiment using 1-NP as an enzyme inducer yielded slight elevations in activities o f
Table 1.1 Experimental / control enzyme activity ratios in rats [from reference 
( 1. 110)].
Enzvme 1-NP 4-NP 1,3-DNP 1,6-DNP 1,8-DNP
Cvtochrome P450 1.6 0.8 2.2 1.5 1.9
Aryl Hydrocarbon 
Hydroxylase
l.l 0.8 1.2 0.9 1.5**
7-Ethoxycoumarin
Deethylase
1.4 - 1.1 1.4 1.4*
Aminopyrine N- 
demethylase
1.3 - 1.4 1.3 1.5*
Epoxide hydrolase 0.9 0.8 0.8 0.9
1 -NP reductase 1.7* 3 .8*t 2.5*t§ 2 .9* t
Cytochrome C reductase 1.1 - 1.1 1.0 1.1
* Significantly different from solvent-treated control (P s 0.05) by student's /-test.
{ Significantly different from 1,6-DNP (P s 0.05) by student’s /-test,
t  Significantly different from l-NP (P s 0.05) by student's /-test.
§ Significantly different from 1,3-DNP (P s 0.05) by student's /-test.
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NADH-Cytochrome b5 reductase and epoxide hydrolase (1.111). Oxidative metabolism 
of 1-NP was not altered, and oxidative metabolism of 1,6-DNP was not detected.
Phase II enzyme induction was evaluated in another rat study (1.112). 1-NP, the 
inducing agent, significantly elevated UDP-glucuronyltransferase levels. It also increased 
conjugation o f l,2-dichloro-4-nitrobenzene, but not l-chloro-2,4-dinitrobenzene, with 
glutathione by a cytosolic glutathione S-transferase. No significant effects were observed 
on sulfotransferases at pH 7.4. DNPs were not used as inducers because of their structural 
similarity to 1-NP.
Pretreatment o f rats with 1-NP caused microsomal nitroreductase activity to 
double, evidenced by appearance o f twice the amount o f l-amino-6-nitropyrene as 
occurred in controls (1.111). Enzyme inhibition studies suggested that more than one 
microsomal nitroreductase enzyme was involved in the reaction. In the same study, 
cytosolic nitroreductase activity was also doubled by 1-NP pretreatment, and the increase 
was not attributable to xanthine oxidase or DT-diaphorase. Other inducers have increased 
DNP nitroreductase activity. For example, ArocIor-1254 increased NADPH-quinone 
reductase (NQOR) activity fivefold toward DNPs (1.83). Benzo(a)pyrene pretreatment 
was associated with a 60-fold increase in binding of DNPs to DNA, but the effect was not 
attributed specifically to enzyme induction (1.19).
Identities of nitroreductases
Mammalian nitroreductase activity is divided between cytosolic, microsomal and 
mitochondrial flavoenzymes that are known for other primary functions [reviewed in 
introduction to (1.80)]. A subset of nitroreductases is capable o f reducing DNPs,
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including the microsomal enzymes NADPH-cytochrome P450 reductase in tandem with 
cytochrome P450 (1.67, 1.111); the cytosolic enzyme NADPH-quinone oxidoreductase 
(1.83); and xanthine oxidase (1-NP only) (1.82, 1.113).
Fractionation o f cytosolic DNP nitroreductase activity from rat livers yielded 
multiple proteins with different nitro- or nitrosoreductase properties (1.79). All pure 
nitroreductase activity was attributable to a single protein, MW -500,000, with metabolite 
formation independent o f oxygen or FMN concentrations. Numerous smaller molecular 
weight protein fractions demonstrated reductase activity toward l-nitro-6-nitrosopyrene. 
Nitroreductase activity in these rats was not inhibited significantly by dicoumarol, nor 
supported by hypoxanthine. Therefore, xanthine oxidase and NQOR (NQOR) were 
apparently not involved in DNP nitro reduction in uninduced or 1-NP-induced rats. In 
contrast to these findings, DNP nitroreductase activity clearly was ascribed to NQOR 
following pre-induction with Aroclor 1254 (1.83). This suggests that exposure o f animals 
to DNP-containing pollutant mixtures could lead to extreme variability in both total 
nitroreductase activity and the source of that activity.
Tumors
Malignant fibrous histiocytomas were produced in rats and mice near the site of 
injection following parenteral administration of 1,6- or 1,8-DNP (1.107, 1.108). Of a 
group receiving 1,3-DNP, only two of 35 rats developed malignant fibrous histiocytomas. 
Subcutaneous injection o f 1-NP, 1,3- and 1,8-DNPs produced fibrosarcomas resembling 
the malignant fibrous histiocytomas, but no other tumors, at the injection site of 
F344/DuCrj rats (1.114, 1.115). Six-week-old CD-I mice also developed malignant
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fibrous histiocytomas following subcutaneous dosage with 0.1 mg 1,6-DNP (1.116) or 
0.05 mg 1,8-DNP (1.117). These tumors were transplantable.
Mammary adenocarcinomas and fibroadenomas were seen in 50-60% o f weanling 
female CD rats which received repeated intraperitoneal injections of 1,3-, 1,6-, or 1,8-DNP 
(1.107). Oral treatment likewise appeared to lead to mammary tumor formation, but these 
tumors also were found in the untreated controls. However, tumors in the treated group 
generally appeared earlier than in controls, and the ratio o f adenocarcinomas to 
fibroadenomas was distinct in treated and control values.
Two types of tumors were found in exposed lung tissues. Squamous cell 
carcinomas developed in the lungs of 4-week-old male F344/DuCrj rats following 
implantation of a lung lobe with 1,6-DNP in beeswax/tricaprylin (1.118). Tumorsdidnot 
form at 0.003 mg 1,6-DNP, but tumor incidence increased up to a maximum o f  85% of 
exposed animals at 0.1 mg (1.119). Adenocarcinomas were formed following tracheal 
infusion of a DNP suspension three times weekly over twenty-six weeks (1.108, 1.120). 
A single report exists of a lung tumor in a human, from which 1-NP, 1,3-DNP and 
chrysene were isolated (1.121). There was no cause-effect relationship established. The 
patient, an elderly Japanese fanner, also had silicosis.
Twenty percent of CD rats receiving 1,8-DNP intraperitoneally also developed 
leukemias (1.107). The incidence o f pituitary carcinomas in oral-treated groups tended 
to be higher than in solvent-treated controls. Three animals receiving 1-NP developed islet 
cell carcinomas, as did one receiving 1,8-DNP. Notably absent from all but one study 
were liver tumors, which is surprising in light of the distribution data o f Shah (1.101). The
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single report o f hepatocarcinogenesis was a low incidence o f tumors o f male, but not 
female, newborn mice following exposure to DNPs (1.122).
The method o f dosing appears to have affected the type of tumor formed. 
Implantation of the wax pellets into the lungs induced local granulomas in all groups, and 
the epithelium o f adjacent bronchi underwent stratification and squamous metaplasia 
(1.118), suggesting that the metaplastic bronchial epithelium, rather than alveolar cells, 
was the transformed cell type. Similarly, Imaida et al. pointed out the possibility that 
malignant fibrous histiocytomas are a product o f an inflammatory response to precipitated 
DNPs at the site o f  administration (1.107).
Studies with DNA adducts
The DNA adducts formed from DNPs in vivo are identical to those formed in cell 
cultures and in bacteria (1.123-1.125), and were highest in bladder and liver following 
dosing (1.111). For example, '(deoxyguanosin-8-yl)-l-amino-8-nitropyrene was isolated 
from mammary, mesenteric, bladder, lung, kidney and liver tissues o f groups of 225 g 
female rats treated with 300 //g 1,8-DNP (1.126). Over the subsequent two weeks, 
adducts were lost from DNA in a biphasic pattern, showing an initial rapid decline, 
followed by a slower rate o f adduct removal.
Intratracheal administration of DNP mixtures into male CD-I mice (1.19) led to 
adduct formation in lung DNA. Pre-induction with benzo[a]pyrene into the trachea 24 hr 
earlier increased radio labelled DNP binding to lung tenfold at 4 and 28 hr, but not at 172 
hr after administration. A twofold increase in nitroreductase activity from pretreatment 
with 1-NP yielded only slight increases in DNP-DNA adducts in all tissues but bladder and
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kidney, in both of which a 60% increase was observed (1.111). Incubation o f  cytosols 
from these rats with DNA in vitro was associated with a doubling in DNA binding, 
suggesting that adduct formation in vivo does not follow nitroreductase activity directly. 
Oncogene mutations
DNA adduct formation from 1,6- and 1,8-DNP (1.108, 1.127,1.128) was followed 
by mutations in oncogene sequences in rat fibrosarcomas. Transfection of this DNA into 
a mouse cell line yielded transformants with rat W-ras or N-ras sequences. A c-Ki-ras 
gene sequence from a fibrosarcoma contained a G -  T transversion in codon 12, causing 
substitution of cysteine for glycine at translation (1.129).
Biomarker studies
DNA and protoporphyrin IX (ppIX) adducts have been considered for use as DNP 
exposure biomarkers in laboratory rats. 1-NP was found to bind to peripheral blood heme 
at 0.08% of the administered dose, or picomolar quantities o f DNP equivalents per mg of 
ppIX at 1 mg/kg dose. Binding for 1-NP was linearly related to dose over five orders o f 
magnitude, yielding an adduct with a circulating half-life of 13 days (1.130). This 
reportedly is about the same rate as most other xenobiotics examined (1.130, 1.131). 1,6- 
DNP was found to bind to heme at about half the extent of 1-NP binding.
The study of DNA adducts as biomarkers was compared to lymphocyte mutations 
in the work of Smith et al. (1.123). In this study, DNA adducts were observed to increase 
up to a level of 3 finol DNA adducts//ug DNA by the seventh day past administration of 
100 (j.g 1,6-DNP in beeswax/tricaprylin. Adduct levels then tapered off over the 
succeeding three weeks to a third o f that level. The splenic lymphocyte adduct load was 
a tenth as high at all time points.
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In this study, lymphocyte mutations at the HGPRT locus began to increase around 
12 weeks following dosage. The rate o f increase in numbers o f mutations was highest in 
animals that had received the highest dose. No other studies have been reported on 
biomarkers of early effects.
Statements of Hypotheses
The current research was directed at identifying biomarkers o f biologically effective 
dose, or biomarkers o f effect. Literature reports exist where adducts o f DNA (1.123), 
albumin (1.130), or protoporphyrin IX (1.132) were evaluated for that purpose. A 
lymphocyte mutation assay was used as a biomarker o f effect (1.123). No reports were 
found describing in vivo clastogenicity; thus, the clastogenic response to DNP exposure 
that was observed in vitro had not been observed to occur in whole animals.
The first hypothesis was that DNPs are relatively insoluble in tissues. This 
hypothesis arose from the reports of having identified unmetabolized DNPs at the site o f 
parenteral administration some months after parenteral administration, discussed 
previously. This hypothesis would be evaluated by measuring the water and plasma 
solubility of 1,6- and 1,8-DNP. The log P values then would be calculated for DNPs and 
their reduced intermediates. The log P values then could be compared to the known 
solubility of DNP in water or plasma, and their solubility in commonly available organic 
solvents.
The second hypothesis was that the expression o f a DNP biomarker depends upon 
not only the level o f exposure to DNP, but to nitroreductase activity as well. This 
hypothesis was formulated based upon studies reviewed above, which point out the
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requirement for nitroreduction o f DNPs in order that their genotoxicity be expressed, and 
upon the studies where DNP nitroreductase activity was induced.
The third hypothesis was that DNP-DNA adducts would be formed in analytically 
useful quantity following experimental exposure to DNPs. As described previously, the 
formation of DNA adducts has been observed to be nonlinear at higher doses, so the 
emphasis of the current work was to be directed at measuring adduct formation at lower 
doses o f DNP. Although preliminary work was done on this hypothesis (presented in 
Chapter 2), no tests were done, and it will not be discussed further.
The fourth hypothesis was that DNP adducts o f protoporphyrin IX (ppIX) could 
be found in analytically useful quantity, either in liver tissue or in the intestinal tract 
following excretion in the bile. Higher levels o f ppIX adducts would be expected in liver 
tissue than blood because of the liver’s more extensive nitroreductase activity. Likewise, 
the fraction of ppIX eliminated in the bile would be expected to be enriched in ppIX 
adducts because of the shorter half-life o f the ppIX adduct as compared to intact ppIX 
(1.130).
The final hypothesis was that oral exposure to DNPs causes chromosome lesions 
that can be evaluated in a micronucleus test or by DNA analysis. If correct, this hypothesis 
would extend the findings o f clastogenicity in vitro to live animals.
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Chapter 2 
Chemical and Analytical Methods
Materials and Equipment
Chemicals, solvents and reagents
Acetic anhydride, formic acid (88%), ammonium hydroxide (29.6%), toluene, 
hexane, tetrahydrofixran, ether, and glacial acetic acid were obtained from Mallinckrodt 
Specialty Chemicals, Paris, KY. Pyrene, Raney® Nickel, sodium chloride, sodium sulfate, 
Sephadex G-10, sodium acetate. DNAse I, type IV, bis-tris buffer, magnesium chloride, 
deoxynucleoside standards, zinc acetate, and hydrazine were from Sigma Chemical 
Company, St. Louis, MO. [l4C]-Pyrene, m-chloroperoxybenzoic acid, silica gel (Merck 
grade 9385, 230-400 mesh 60A), and sodium hydroxide were from Aldrich Chemical 
Company, Milwaukee, WI. Nitric acid (70%), sulfuric acid (95%), methanol, ethyl 
acetate, chloroform, n-butanol, and ethanol were from Curtin-Matheson Scientific, 
Houston, TX. Thin-layer chromatography (TLC) was done on Kieselgel-60 F254 silica 
plates (0.25 mm, 5 * 1 0  cm, 20 * 20 cm) from E.Merck, Darmstadt, Germany. Phenol- 
chloroform-isoamyl alcohol, acrylamide, bis-acrylamide, sodium dodecylsulfate, TEMED, 
ammonium persulfate, and guanidine isothiocyanate were from Amresco, Solon, Ohio. 
The Bicincholinate assay for protein was from Pierce Chemicals, Rockford, IL. 
Analytical equipment and supplies
HPLC analyses were performed on one of two columns. A 4.6 * 250mm, 5/um 
C l8 reverse-phase column, equipped with a high-performance reverse-phase guard 
column, was obtained from Vydac, The SepArations Group, Hesperia, CA. A 10 * 250 
mm cyanopropyl column (CN column) was obtained from Phenomenix, Torrance, CA.
38
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HPLC analyses were conducted on four different systems. Most assays were done on a 
Shimadzu LC-600 pump, fitted with a Rheodyne 7125 injector and a 1 mL sample loop, 
using a dual-wavelength Shimadzu SPD-10AV uV/Vis detector. A Waters 600MS system 
controIler/HPLC pump was fitted to a Hewlett-Packard 1040A diode array detector for 
some analyses. A Hewlett-Packard HP 1090 Liquid Chromatograph and diode array 
detector were used with assays using the cyanopropyl column. Mass spectra were 
obtained using a VG Qualtro IIGC/LC/MS/MS system, with analysis in the atmospheric- 
pressure- chemical-ionization, negative-ion detection mode. Molecular ion (M‘ and MH') 
species were used to monitor and identify individual isomers and reduced metabolites.
Two 10 ><120 cm glass chromatography columns were custom-made in the 
Chemistry Department Glass Blowing Shop at Louisiana State University. The columns 
were fitted with coarse frits, and were glass-jacketed so that temperature could be 
controlled with circulating water.
A Buchi rotary evaporator, from Brinkmann Instrument Company, Westbury, NY, 
was used for large-scale distillation o f solvents from synthesized products.
Syntheses and Purifications
Dinitropvrenes
A mixture of DNPs was prepared by nitration of pyrene (2.1). A typical synthesis 
was conducted by dissolving 15 g pyrene in 360 mL 1:1 acetic acid:acetic anhydride at 
60°C. Two equivalents of nitric acid (9.6 mL) were added dropwise to this solution, and 
the mixture was stirred at 50°C for 2 hr. After cooling to room temperature, the yellow 
precipitate was collected by filtration. The crude product was dissolved in toluene (200
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mL) at 70°C for 20 min, then precipitated on ice. The dissolution and precipitation were 
repeated, followed by washing o f the final precipitate with toluene and methanol, then 
drying overnight under a vacuum. The final yield was 13 g o f a mixture o f 1-nitropyrene 
(1-NP), 7.3%; 1,3-DNP, 13.7%; 1,6-DNP, 38.1%; and 1,8-DNP, 40.9% fHPLC Method 
1  below).
Individual isomers were separated on silica gel using the 10 * 120 cm glass column 
heated to 70°C. Pure 1,3-DNP was separated from 1,6- and 1,8-DNP using a 6:4 
toluenerhexane eluant. 1,6- And 1,8-DNP were resolved from each other by re-application 
to the column, and elution with a solvent consisting of 60% toluene: 35% hexane: 5% 
pyridine. Solvents were distilled from the pure isomers using the rotary evaporator.
Radio labelled DNPs were synthesized in the same basic manner as unlabelled 
DNPs, but nitration did not proceed as readily. [4,5,9,10-HC]-pyrene (39 mCi/mM, 25 mg 
total) were dissolved in 100 mL acetic acid:acetic anhydride, and the mixture was warmed 
to 60°C. Addition of two equivalents of nitric acid (17.4 /zL) yielded only partial 
nitration, so an additional equivalent of nitric acid was added on each o f three subsequent 
days, with overnight stirring in between. After the third addition, starting material was still 
present, and the major product was 1-NP. Additional nitric acid (5 equivalents) was 
added, followed by overnight stirring. TLC of the yellow reaction mixture in 1:1 
toluene:hexane mobile phase revealed the presence of significant quantities of DNPs. 
Solvents were removed from the products using the rotary evaporator, and the residue was 
washed with ethanol.
Purification of part o f the [l4C]-DNPs was accomplished by loading 20 cm2 silica 
plates with small quantities of the mixture. The plates were developed in a 6:4 mixture of
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toluene and hexane. Individual bands were scraped off and added to hot toluene to 
dissolve the purified DNP isomers. Each plate was capable o f separating only a very small 
quantity o f the initial mixture. Overloading was characterized by formation o f bands of 
isomer mixtures between the pure bands.
Reduction products o f 1.6- and 1.8-DNP
The procedures o f Fifer et al.{ 2.2), and of Howard et al. (2.3) were followed for 
synthesis o f nitroreduced intermediates o f DNPs (Figure 2.1). Briefly, 1-NP was 
synthesized by adding one equivalent o f nitric acid to the pyrene solution. This was 
reduced in hydrazine and Raney® Nickel, then N-acetylated and re-nitrated. The resulting 
mixture o f l-acetylamino-6-nitropyrene and l-acetylamino-8-nitropyrene was separated 
on a silica gel column using pure ethyl acetate as an eluant.
Each isomer was deacetylated by refluxing in equal parts o f glacial acetic acid and 
concentrated HC1. The resulting aminonitropyrenes were oxidized to nitro-nitrosopyrenes 
using m-chloroperoxybenzoic acid. Individual intermediates were purified on silica gel 
according to the original procedure. Identities o f the intermediates were confirmed by 
comparing mass and NMR spectra for each compound with published values.
Pyrene-1,6-diamine was prepared by direct reduction of 1 mg 1,6-DNP using 50 
fxL hydrazine and Raney® Nickel. Quantitative conversion to pyrene-1,6-diamine occurred 
following overnight reaction. This was verified by HPLC (see HPLC Method 3 below). 
The identity of the product was verified by APcI mass spectrometry (see HPLC Method3 
and Mass Spectra below).
Preparation of the aminonitropyrenes also was achieved using the Zinin reaction 
(2.4). The DNP mixture (10 mg) was dissolved in 4 mL toluene and 4 mL ethanol. The
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2 HNO
1 HNO
Reflux
1 HNO.
CHjCOOH
Figure 2.1 Reaction sequence for synthesis o f DNP and its reduction products, 
reducing reagent was prepared fresh by addition of sodium sulfide (200 mg) and sulfur (48 
mg) to 1.6 mL deionized water. The mixture was heated until an orange-red solution 
formed. A portion of this mixture (0.2 mL) was added to the DNP solution, and the 
reaction proceeded for 1.5 hr at room temperature. HPLC analysis o f the products 
revealed 85.8% and 80.8% conversion o f 1,6- and 1,8-DNP, respectively, to 
aminonitropyrenes (HPLC Method 3. below, using positively identified standard for uV 
spectral comparison). Separation of the mixture was achieved on a 2.5 * 30 cm silica gel
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column using hexane as an initial eluant, and adding increasing concentrations o f ethyl 
acetate until the pure amine eluted from the column.
A'-hvdroxvl-1 -amino-6-nitropvrene
A procedure has been reported to yield iV-hydroxyl-1 -amino-6-nitropyrene, but the 
final product o f the reaction apparently has not been confirmed by detailed analysis 
(2.5-2.7). l-nitro-6-nitrosopyrene (200 y.%) was combined with 2 mg sodium ascorbate 
in sparged 50 mM phosphate buffer, pH 7.4. The reaction mixture was allowed to stand 
for 2 hr. HPLC analysis of an aliquot of the reaction mixture (HPLC Method 3. Chemical 
Analyses) revealed the presence of a peak eluting slightly earlier (lO.Olmin) than an 
authentic standard for l-amino-6-nitropyrene (10.6 min). The retention time was 
consistent with the estimated order o f elution from an HPLC column, based on a 
calculated log P value for the compound (Chapter 3). A spectrum o f this peak, obtained 
by photodiode array, had a broad absorption, with a peak (A ^  460-470 nm) near that of 
l-amino-6-nitropyrene (Amax 493 nm). This compound was unstable, so further 
characterization of its identity was not done.
DNA adducts—preliminary attempts
Attempts were made to synthesize a DNP-DNA adduct following a published 
procedure (2.7). A mixture of DNA, l-nitro-6-nitrosopyrene, and ascorbate were 
prepared as described, and allowed to incubate overnight. Following extraction o f the 
reaction solution, the DNA was eluted from a Sephadex G-10 column using ultrapure 
water to further ensure removal of non-covalently bound derivatives of DNP. The DNA 
that was recovered and precipitated (3.3 mg of 5 mg starting material) was observed to 
be pink in color.
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Acid-catalyzed cleavage o f alkylated purines from the DNA was attempted (2.8). 
HPLC analysis using conditions reported in the synthetic procedure (2.7) completely failed 
to resolve the reaction mixture; a single, broad peak began eluting at 10 min and continued 
for the following 7 min. Enzymatic cleavage of the DNA (2.9), followed by butanol 
enrichment (2.10), yielded 2.2 micromoles DNA bases in the enriched fraction. Duplication 
of the HPLC conditions used in the enzymatic procedure (2.9) yielded a series o f peaks 
that did not elute with deoxyguanosine or deoxyadenosine standards, nor with l-nitro-6- 
nitrosopyrene or l-amino-6-nitropyrene. Further work on this project was deferred until 
the supply of 1-nitro-6-nitrosopyrene was replenished. A summary that was written just 
after completion of these procedures included a suggestion that exposure to air or light 
may have caused the DNA adduct to decompose.
Protoporphyrin IX adducts—preliminary work
It was assumed that the aryl nitrenium ion that reacted with DNA also was the 
intermediate that reacted with ppIX. Therefore, efforts were undertaken to react 
protoporphyrin IX (ppIX) with l-nitro-6-nitrosopyrene using the method for synthesizing 
DNA adducts (2.9). PpIX (1 mg) and l-nitro-6-nitrosopyrene (0.67 ^mol) were dissolved 
in -10  mL o f an argon-sparged solution o f DMSO:citrate (4:1 DMSO:10mM sodium 
citrate, pH 5.0). Sodium ascorbate (0.6 mg) was added, and the mixture was stored at 
room temperature overnight under argon. The following day, argon-sparged chloroform 
was added to the reaction mixture in an extraction funnel until phase separation occurred. 
The extraction mixture was shaken and allowed to settle. The chloroform layer was 
transferred to another separation funnel, and the aqueous layer was discarded. The 
chloroform layer, containing intact ppIX, and probable ppIX adducts, was washed 5-6
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times with argon-sparged water to remove DMSO, and chloroform was evaporated with 
argon. The resultant wet suspension was dissolved in 20 mL 19:1 methanoksulfuric acid 
(2.11, 2.12) and allowed to incubate for 12 hr at 4°C, to esterify the carboxylic acid 
moieties o f ppIX with methanol. Chloroform and water (40 mL each), both argon- 
sparged, were added to the reaction mixture to extract the esterified ppEX. The 
chloroform layer was washed several times with argon-sparged water until the acid was 
removed. Zinc acetate was added to complex with the ppIX methyl ester and stabilize it.
Attempts to resolve this material using TLC were unsuccessful because of the 
formation of an immobile brown or black spot on the TLC plate, probably from oxidation. 
HPLC was conducted using a gradient of 30-100% acetonitrile in 3:2 
methanoktriethylamine citrate over 15 min. Three peaks were detected (UV absorbance 
measured at 412 nm) as they were eluted from a C18 column. The major peak at 13 min 
co-eluted with a ppIX methyl ester standard. Peaks at 8.7 and 9.9 min co-eluted with 
authentic l-amino-6-nitropyrene and l-nitro-6-nitrosopyrene standards. Further efforts 
at chemical synthesis of the ppIX adduct were suspended.
Chemical Analyses 
HPLC Method 1: Resolution o f DNP isomers
A Hewlett-Packard HP 1090 Liquid Chromatograph and an HP diode array 
detector set at 390 nm were used to deliver a toluene:hexane gradient through a 10 * 250 
mm cyanopropyl column (CN column) at 3 mL/min. Initial conditions of 30% toluene 
were held for 2 min. followed by a rise to 50% toluene over the following 20 min. Under 
these conditions, elution times for authentic standards of 1-nitropyrene, 1,3-, 1,6-, and 1,8- 
DNP were 9.9, 13.1, 14.9. and 17.0 min, respectively.
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HPLC Method 2: Resolution o f DNP isomers and their nitroreduced products
DNP isomers could be resolved from each other and from the isomers o f  the 
nitroreduced products, except the diamines, on the CN column using a 
toluene:hexane:acetonitrile gradient at 3 mL/min. Solvent A consisted of 30% toluene in 
hexane. Solvents B and C were toluene and acetonitrile, respectively. Initial conditions 
o f 30% solvent B in solvent A were held for 2 min, then changed linearly to solvent A: 
30%; solvent B: 40%; and solvent C: 30% at 22 min. These conditions were held for 5 
min. A 15-min re-equilibration was used between injections. DNPs and their reduced 
metabolites were eluted at the following times (min): 1-nitropyrene, 6.99; 1,3-DNP, 7.51;
1.6-DNP and l-nitro-6-nitrosopyrene (NONP), 8.28; 1.8-DNP, 8.78; 1,8-NONP, 9.79; 
1-amino-8-nitropyrene (ANP), 14.13; and 1.6-ANP. 14.47.
HPLC Method 3: Resolution of DNP and reduction products—single isomer
Individual DNP isomers and their nitroreduced metabolites were resolved using a 
C l8 reversed-phase column. Product detection was accomplished by measuring 
absorbance of the eluate (420/475 nm). A linear gradient o f 35-100% acetonitrile in 25 
mM ammonium acetate at 2 mL/min over 15 min caused 1,6-diaminopyrene to elute at 7.6 
min; l-amino-6-nitropyrene at 11.6 min; 1,6-dinitropyrene at 14.2 min; and l-nitro-6- 
nitrosopyrene at 15.2 min. In some studies, the gradient was steeper, rising to 100% 
acetonitrile over as little as 10 min. The peak elution order remained constant under all 
conditions.
HPLC Method 4: Protoporphyrin IX
The Shimadzu pump and detector (412/543 nm) were used with the C l8 reversed- 
phase column to analyze tissue and cecal samples for ppIX adducts. The mobile phase
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consisted o f two solvents used in a gradient at 1.5 mL/min. Solvent A consisted o f 900 
mL 100 mM ammonium acetate and 100 mL acetonitrile. Solvent B was prepared by 
adding 300 mL acetonitrile to 700 mL methanol. The gradient was 40-100% solvent B 
over 26 min, then hold for an additional 15 min. Re-equilibration was found to require 15 
min, as shorter equilibrations tended to be followed by irregular peak elution times in the 
subsequent run. Under these conditions, an authentic ppIX standard eluted at 29 min. 
APcI Mass spectra
Individual nitroreduced products were assayable on a C l8 column and a 25 mM 
formic acid/acetonitrile gradient similar to the method used for assay of an individual DNP 
isomer and its metabolites, above. The column temperature was set at 40°C, and the flow 
rate maintained at 1 mL/min. Under these conditions, the elution times were slightly 
different from HPLC Method 3, but the order o f elution remained consistent. Spectra 
were acquired using the VG Quattro II GC/LC/MS/MS system and analyzed by ApcI in 
the negative ion mode. Molecular ion (M‘ and MH') species were used to monitor and 
identify individual isomers and reduced metabolites. The spectra for the negative ions of 
each product are as follows:
Isomer MW m/z (%)
Protein analyses
Serum albumin was measured on an Olympus Reply (Irving, TX) automated 
autosampler, using a DMA (Arlington, TX) Bromocresol Green Reagent test kit. Total 
serum protein was measured on the same instrument using a DMA Modified Biuret
pyrene-1,6-diamine 
1 -amino-6-nitropyrene 
1 -nitro-6-nitroso pyrene
1,6-dinitropyrene
232
262
276
292
232(100); 231 (85); 204 (25) 
262 (100); 232 (20) 
276(100); 262 (30); 246 (58) 
292 (50); 262 (100).
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Reaction kit. Both tests were conducted by the Clinical Pathology Laboratory at the 
Louisiana State University School o f Veterinary Medicine. Protein contents on 
microsomes and cytosols were measured by the bicincholinate assay (Pierce), according 
to the manufacturer's instructions. Samples were incubated for 30 min at 37°C prior to 
measurement o f absorbance. Bovine serum albumin was used as a reference.
SDS-polyacrylamide gel electrophoresis was performed in a Mini-Protean II unit 
(BioRad, Hercules, CA) using 10% polyacrylamide gel. Buffers were prepared according 
to the instructions that came with the unit. A BioRad Kaleidoscope pre-stained protein 
standard was used as a molecular weight marker (range 6900-202,000). Electrophoresis 
was continued until the low-molecular weight standard neared the bottom of the gel, about 
45 min. Gels were stained with coomassie blue.
Isolation of Samples for Adduct Analyses
Nucleic acids
Nucleic acids were isolated from tissues using an adaptation of a guanidine 
thiocyanate method (2.13). For this procedure, solutions o f guanidine isothiocyanate 
(GITC, 3M) and sodium chloride (5M) were prepared in deionized distilled water. One 
part tissue was removed from a live animal, immediately placed into 30 parts (wt:volume) 
GITC, and homogenized with a Wheaton homogenizer. The resultant nucleic acid solution 
was reported in the original procedure to be stable at this stage for a period o f months at 
room temperature. Nevertheless, samples were not stored longer than overnight before 
DNA was isolated from them. Proteins were extracted from the solution with unbuffered 
phenol:chloroform:isoamyl alcohol (PCA). Emulsions, which formed occasionally, were
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broken by adding half an additional volume o f GITC, re-mixing, then repeating 
centrifugation. The bottom (organic) layer containing proteins was discarded. Nucleic 
acids were precipitated from the aqueous layer by addition o f 0.1 volume of sodium 
chloride, followed by a volume of 100% ethanol equal to the total o f the aqueous layer and 
added sodium chloride. The nucleic acids were pelleted by centrifugation, washed with 
ethanoL. and stored in ethanol at -20°C. The A260/2g0 ratio, an indication of relative protein 
contamination, was 1.90.
P p IX
Isolation of ppIX from liver and cecal samples was done by a method utilized for 
development of an automated procedure (2.14). Cecal contents (-0.75 g) were added to 
a 10-mL glass Wheaton homogenization tube with a loose-fitting pestle, and homogenized 
in 1.5 mL concentrated HC1. An equal volume of water was then added, followed by 3 
mL ether. The aqueous and organic phases were re-mixed by homogenization, and then 
centrifuged to speed phase partitioning. The pigmented aqueous layer was sampled 
immediately for HPLC analysis. Liver tissue was handled in an identical manner, with two 
exceptions. Prior to addition of HC1, the tissue was thoroughly homogenized without 
added buffers. Also, liver pigments partitioned into the organic layer, rather than the 
aqueous fraction. This difference in partitioning was confirmed in experiments using 
spiked liver and cecal specimens, and was found to occur in spiked samples of water. 
Therefore, the organic layer of liver extracts was evaporated under argon, and the residue 
was redissolved in 0.3 mL dimethylformamide. An aliquot of this material was passed 
through a Nalgene 0.45/u nylon syringe filter (Nalge Company, Rochester, NY) prior to 
HPLC analysis.
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Chapter 3 
Solubility and Log P
Introduction
As discussed in Chapter 1, the absorption o f DNPs from the gastrointestinal tract 
o f  mice was found to be very low. Likewise, absorption following parenteral 
administration led to formation o f DNP precipitates that were still present after two 
months. These observations led to questions about the solubility properties o f DNPs and 
their metabolites. Thus, the data on solubility and related properties, e.g., log P, were 
measured or calculated in the current study.
Materials and Methods
1,6-DNP and l,6-dinitro-[4,5,9,10-I4C]-pyrene were synthesized in our laboratory 
as described in Chapter 2. Whole blood (64 mL) was obtained from laboratory rats and 
diluted to 75 mL with acid citrate-dextrose anticoagulant containing 9 mg sodium azide 
as a preservative. The blood was centrifuged for 1 hr at 105,000 * g, and the plasma was 
harvested, yielding 28 mL. A control experiment was performed on plasma to measure the 
actual dilution rate, using albumin concentration as a reference ('Protein analyses. Chapter 
2). Undiluted heparinized plasma was found to have 3.1 mg/dL albumin, and 2.1 mg/dL 
albumin concentration following dilution with acid citrate-dextrose.
Plasma and water solubility were determined by a standard method (3.1). For 
plasma studies, 1.2 mg l,6-dinitro-4,5,9,10-[I4C]-pyrene (33 //Ci/mM) were dissolved in 
hot toluene and divided evenly between three 25-mL erlenmeyer flasks. The toluene was 
dried under argon in such a way that the DNP residue adhered to the sides o f the flask. 
Plasma (4.7 mL/flask) was added, the flasks were sealed with rubber stoppers, and shaken
52
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at moderate speed on a wrist-action shaker for 24 hr. The liquid contents of each flask 
were then centrifuged for 3 hr (10,000 * g), and aspirated into a syringe. A 0.45 (j.m 
syringe filter (Nalge Company, Rochester, NY) was attached to the syringe, and sequential 
0.5 mL portions were filtered into 8-10 individual tubes. The first and final fractions 
contained nonuniform volumes, resulting from filter loading and differences in final 
volume, respectively. These were excluded from analyses. All other fractions were 
counted in a Packard TriCarb 1900TR Liquid Scintillation Counter using Hionic Fluor 
Scintillation cocktail (Packard Instruments), and radioactivity was plotted against fraction 
number. The late filtrates, which emerged following saturation of binding sites on the 
filter, were utilized to estimate the plasma solubility. An identical procedure was 
performed to measure the plasma solubility o f l,8-dinitro-4,5,9,10-[uC]pyrene. Water 
solubility was measured by the same method as with plasma, except that the starting 
amount of radiolabelled DNPs per flask was 0.001//M (39.2 mCi/mole).
Log P values were calculated for DNP and its metabolites according to the method 
of Hansch and Leo (3.2), as outlined by Lyman (3.3). Calculations were begun using the 
fragment value of pyrene as a skeleton. The log P values o f substituent functional groups 
(fragments) were added to or subtracted from the starting value as indicated. Literature 
values published for DNP and l-amino-6-nitropyrene (3.4) are presented for comparison. 
These values could not be traced to their original sources. Literature estimates were not 
available for the other intermediates.
Results
The results o f log P calculations are presented in Table 3.1. The values for log 
P of the DNP congeners agree well with the order o f their elution from a reverse-phase
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HPLC column. The water and plasma solubilities o f 1,6- and 1,8-dinitropyrene are 
presented in Figure 3.1. Some difficulty was encountered with plugging of syringe filters 
in these experiments; the variability evident in the plot o f 1,6-DNP water solubility may 
have been due to a damaged filter membrane in the one series with the highest values. 
Thus, the estimated water solubility is 30-35 ppb. In the plasma solubility experiments, a 
yellow precipitate, believed to be fibrin, formed in some flasks. Despite this, the data were 
fairly tightly grouped, and yielded an estimated DNP plasma solubility o f approximately 
800 ppb.
Discussion and Conclusions
The values of log P for DNP and its reduced intermediates agree with their order 
o f elution from an HPLC column (Chapter 2, HPLC Method 3L suggesting that the log 
P predictions for this series o f compounds are of proper value relative to each other. A 
second means of evaluation of the log P values is to compare the calculated value with an 
actual ratio of solubilities of the compounds in pure water and in pure toluene. While not 
strictly correct because neither the toluene nor water is likely to be saturated with the other 
solvent, this comparison may still be useful for DNPs because their solubility is very low.
The water solubility o f DNP is about 0.035 ppm. It has been found in the course 
o f work with DNPs that the maximum amount o f 1,6- or 1,8-DNP that can be dissolved 
in toluene is about 200 ppm. Using that value, the actual ratio is 5700. If octanol were 
substituted for toluene, the amount of dissolved DNP very likely would be lower, resulting 
in a narrower ratio. Further narrowing would be expected if both solvents were saturated 
with each other.
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Table 3.1 Log P values for 1,6-DNP, its nitroreduction intermediates and their 
acetylated derivatives, as calculated by the method o f Hansch and Leo (3.2). The final 
log P value is the algebraic sum of the contributions o f each substituent, specified under 
'fragment’. Literature values and HPLC elution time are provided for comparison.
0 * ^ 0
O O
V
'o
1-Ac-
Fragment 1,6-DNP
l-N-6- 
1-N—6-NOPNHOH-P
1-AcO-
NH-6-NP
NH-
-6-NP 1-A-6-NP P-1,6-DA
Pyrene +4.88 +4.88 +4.88 +4.88 +4.88 +4.88 +4.88
-2 -H (f*) -0.46 -0.46 -0.46 -0.46 -0.46 -0.46 -0.46
+ -NO, -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 __
+ -NO, -0.03 — — — — — —
+ -N =0 — +0.11 — — — — —
+ -NHOH — — -1 .11 — — — __
+ -NH- — — — -1.03 — — —
+ -NH, — — — — — -1.00 -1.00
+ -NH- 
-C(0)H -0.64
+ -0 C (0 ) 
-NH. -0.82
- -NH, _ — — + 1.00 — — —
-H — — — — -0.23 — —
+CH? — — — -0 .89 +0.89 — —
+NH, - - - - — - -1.00
(T o ta l) 
Log P5 4.36 4.50 3.28 4.43 4.41 3.39 2.42
Log P, 4.63 4.69 3.47 4.16 3.77 3.62 2.61Method 21
Compare 4.44 3.63Literatur
LC Time 14.01 15.15 -10.9 - 7.8 11.71 6.5
5 Manual method of Hansch,C, and Leo,A.J., (3.2).
'  Software method based on Hansch,C, and Leo,A.J., (3.2).
° Reference (3.4) contains values erroneously attributed to (3.5). Actual source 
unknown.
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1,6-DNP 1,8-DNP
Water
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0.04 -I
0.02  -
0.00 T
8 10 0 8 10
Plasma
1.0  -
0.8  -
0.6  -
0.4 -
0.2 -
0.0 i i--------- r
10 0 2 8 104 6
Fraction number
Figure 3.1 Water and plasma solubilities o f 1,6- and 1,8-DNP are about 35-40 ppb in 
water, and 800-900 ppb in 70% plasma/30% anticoagulant. Each point was one of a 
series o f 0.5 mL filtrates, 4.5-5 mL total volume per filtrate. Measures were obtained 
after 24 hr at room temperature. One o f the syringe filters used to measure the 1,6- 
DNP water solubility may have been defective, resulting in artifactually high values.
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From Table 3.1, the calculated octanol-water partition coefficient for DNP 
(predicted P = 25-35,000) is at least fivefold higher than the unadjusted actual 
toluenerwater ratio. This magnitude o f error is typical of results obtained from linear free 
energy equations o f the general form
log — = m * log P + bs
that have been derived from series of compounds unrelated to the compound of interest. 
Percent errors of such calculated values have been found to be very large (lOMO4) in some 
cases, e.g., with hexahydro-1.3,5-trinitro-l,3,5-triazine (3.6). Errors of this magnitude 
therefore may exist for the other calculated log P values in Table 1.
The apparent plasma solubility o f DNPs was approximately 20 times higher than 
the solubility in water. This figure may be misleading due to the possibility o f  spontaneous 
nitroreduction (Chapters 4 and 5). In the current study, spontaneous nitroreduction could 
have been coupled to oxidation of oxidizable functional groups on the plasma proteins, 
with formation of reduced intermediates that are more soluble than DNP. Additionally, 
a portion o f radio label may have been bound covalently to soluble proteins (3.7). Thus, 
without product analysis, it cannot be stated convincingly that the value obtained for 
plasma solubility reflects DNP solubility alone. It should be noted that the proteinaceous 
precipitate in the flasks may have formed as a result of conformational changes attributable 
to oxidation of free thiols or other sites in plasma proteins, rather than from activation of 
the clotting cascade.
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The limited water solubility o f DNPs that was characterized in these studies is not 
surprising, in light of the previous findings o f poor uptake from the intestine (3.8) and from 
parenteral sites of administration (3.9, 3.10). The redox properties of DNPs render it 
premature to accept the findings o f the plasma solubility study without an analysis o f the 
final chemical composition o f the radio label. When that is known, it also may be possible 
to determine that uptake and distribution of DNPs is linked to their nitroreduction.
References
3.1. Means. J.C., Hassett, J.J., Wood, S.G. and Banwart, W.L. (1979) Sorption 
properties of energy-related pollutants and sediments. In: Jones, P.W. and Leber, 
P. (Eds.) Polynuclear Aromatic Hydrocarbons—Third International Symposium 
on Chemistry and Biology—Carcinogenesis and Mutagenesis, pp. 327-340. Ann 
Arbor, Michigan: Ann Arbor Science Publishers. Inc.
3.2. Hansch, C. and Leo. A.J. (1979) Substituent Constants fo r  Correlation Analysis 
in Chemistry and Biology, New York: John Wiley
3.3. Lyman, W.J. (1982) Octanol/waterpartition coefficient, New York: McGraw-Hill, 
Inc.
3.4. Debnath, A.K.. Lopez de Compadre, R.L., Debnath, G., Shusterman, A.J. and 
Hansch. C. (1991) Structure-activity relationship of mutagenic aromatic and 
heteroaromatic nitro compounds. Correlation with molecular orbital energies and 
hydrophobicity. [Review], Journal o f  Medicinal Chemistry. 34, 786-797
3.5. Rosenkranz, H.S. and Mermelstein, R. (1983) Mutagenicity and genotoxicity of 
nitroarenes. All nitro-containing chemicals were not created equal. Mutat. Res. 
114,217-267
3.6. Schwarzenbach, R.P., Gschwend, P.M. and Imboden, D.M. (1993) Anonymous 
Environmental Organic Chemistry, pp. 134 New York: John Wiley and Sons
3.7. Diepold, C., Eyer, P., Kampffineyer, H. and Reinhardt, K. (1982) Reactions of 
aromatic nitroso compounds with thiols. In: Snyder, R., Jollow, D.J., Parke, D.V., 
Gibson, C.G., Kocsis, J.J. and Witmer, C.M. (Eds.) Biological Reactive 
Intermediates-II. Chemical Mechanisms and Biological Effects, pp. 1173 - 1181. 
New York: Plenum Press
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
59
3.8. Shah, A.B., Rowland, I.R. and Combes, R.D. (1990) Distribution and excretion 
of 1.8-dinitro[l4C]pyrene in the mouse. Toxicol. Lett. 51, 303-313
3.9. Imaida, K., Lee, M.S., Wang, C.Y. and King, C.M. (1991) Carcinogenicity o f 
dinitropyrenes in the weanling female CD rat. Carcinogenesis (London). 12, 
1187-1191
3.10. Tokiwa, H., Otofuji, T., Horikawa, K., Kitamori, S., Otsuka, H., Manabe, Y., 
Kinouchi, T. and Ohnishi, Y. (1984) 1,6-dinitropyrene: mutagenicity in Salmonella 
and carcinogenicity in BALB/c mice. JNCIJ. Natl. Cancer Inst. 73, 1359-1363
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 4 
Flavin-Dependent DNP Nitroreduction
Introduction
Biological nitroreduction of nitro-polycyclic aromatic hydrocarbons is considered 
to be an enzymatic process (4.1-4.5). Nitroreductase enzymes exhibit some substrate 
specificity, and can be induced. For example, xanthine oxidase appears to catalyze the 
nitroreduction of 1-nitropyrene (NP), but not 1,6- or 1,8-dinitropyrene (DNP) (4.6,4.7). 
Evidence for inducibility includes a twofold induction o f DNP nitroreduction by prior 
exposure to 1-NP (4.8). and a fivefold induction ofNADPH-quinone oxidoreductase (4.9) 
following exposure to Aroclor 1254. Although not measured as such, a sixty-fold increase 
o f DNP binding to DNA that followed exposure to benzo [a] pyrene (4.10) could have been 
due to enzyme induction.
The DNP nitroreductases include NADPH-quinone oxidoreductase (4.9) and a 
variety o f other cytosolic and microsomal enzymes, some of which may not have been 
characterized (4.7). This diversity o f nitroreductase activity suggests that there are 
multiple possible inductive or inhibitory interactions that would affect the metabolism and 
genotoxicity o f DNPs. Thus, the DNP-specific portion of genotoxicity that occurred with 
exposure to a pollutant mixture would probably be a function not only of the DNP content, 
but also the inductive or inhibitory effects o f the mixture on nitroreductase activity. For 
this reason, it was desired to measure hepatic cytosolic nitroreductase activity in laboratory 
rats following their exposure to pollutant mixtures containing DNPs.
It was found that addition of flavin mononucleotide (FMN) to the nitroreductase 
assays caused a substantial increase in formation o f  nitroreduced DNP products. This is
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consistent with reports o f the activity o f FMN in a number o f nitroreductase assays (4.1, 
4.3,4.11,4.12). Attempts to lower nitroreductase activity by partial or complete omission 
o f cytosolic enzymes from the assays revealed that nitroreduction could proceed in the 
complete absence of enzymes when FMN was present. This reaction has not been 
reported previously for DNPs or other nitro-polycyclic aromatic hydrocarbons. The 
current study describes flavin-dependent chemical nitroreduction of DNPs. Similarities 
between this reaction and nitroreduction o f nitroimidazoles, nitrofiirans. and nitrobenzene 
are discussed.
Materials and Methods
Trichloroacetic acid, reduced nicotinamide-adenine-dinucleotide phosphate 
(NADPH), reduced nicotinamide-adenine-dinucleotide (NADH), FMN, glucose oxidase, 
glucose. Raney® Nickel, Bacterial Protease Type XXIV. 2-(p-iodophenyl)-3-(p- 
nitrophenyl)-5-(phenyl)-2H-tetrazolium chloride (INT), and microsome buffer components 
were obtained from Sigma Chemical Company, Inc., St. Louis, MO. Catalase, citric acid, 
the AtmosBag® and titanium trichloride were purchased from Aldrich Chemical Co., 
Milwaukee, WI. Monobasic potassium phosphate was obtained from Mallinckrodt 
Specialty Chemicals Co., Paris, KY. Acetonitrile and other solvents utilized in chemical 
syntheses and analyses came from EM Science, Gibbstown, NJ. Ultrafree-MC 
ultrafiltration tubes (5 kDa cutoff) were purchased from Millipore Corp., Bedford, MA. 
The Pierce BCA Protein Assay was obtained from Pierce Chemical Company, Rockford, 
IL. 1,6-Dinitropyrene, l-nitro-6-nitrosopyrene, and l-amino-6-nitropyrene, and pyrene-
1,6-diamine were synthesized as described in Chapter 2.
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Four female Sprague-Dawley rats (2 mo) were obtained from the Division of 
Laboratory Animal Medicine breeder colony. Microsomes were induced using 
intraperitoneal treatments with one of the following in 0.5 mL com oil: com oil only; 30 
mg phenobarbital; 5 mg 3-methylcholanthrene; or 37.5 mg isosafrole. Each rat received 
daily doses of a single inducer for 4 da prior to harvesting microsomes. Food was 
withheld after the last dose.
The next day, each rat was anesthetized with isofluorane. The liver was gently 
perfused in situ with ice-cold 1.15% KCl until free o f blood, removed by blunt dissection, 
weighed, and homogenized (0°C) in 0.25M sucrose for 30 seconds using a Tissumizer 
homogenizer (Tekmar Company, Cincinnati, OH). After centrifugation at 10.000 * g  for 
20 min, the postmitochondrial supernatants were spun at 105,000 * g  for 1 hr. The 
cytosolic supernatants o f that centrifugate were aspirated from the microsomes and divided 
into 0.5 mL fractions. These were frozen at -70°C, while microsomes were processed for 
unrelated studies. All centrifuges were pre-coo led and maintained at 0-4 °C. Protein 
assays were performed as described in Chapter 2.
All enzymatic and non-enzymatic nitroreduction incubations were set up and 
conducted in an enclosed chamber. The chamber and 50 mM potassium phosphate buffer 
were pre-sparged with argon for at least 20 min prior to setting up the incubations. 
Cofactors were diluted under argon with sparged buffer, but all other solutions were not 
sparged. Then, incubation mixtures were assembled in warm (37°C) microcentrifuge 
tubes under argon. The cofactors and oxygen-scavenging enzymes were allowed to 
incubate for at least 10 min in closed tubes prior to addition of cytosolic enzymes and 
DNP, to reduce dissolved oxygen concentration to a minimum.
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In some trials, the enzymatic oxygen-scavenging system was omitted from each 
incubation tube. The extreme sensitivity of the assay to the presence o f oxygen 
necessitated use o f chemical oxygen scavenging under those conditions. This was done 
by sealing the experimental apparatus and supplies in an AtmosBag® together with the 
oxygen-scavenging solution and a bubbling apparatus. The bag was then purged o f air by 
three evacuation/inflation cycles using ultrapure argon. After the third inflation, the argon 
was allowed to remain in the sealed bag. Air flow in the sealed bag was generated by two 
oilless diaphragm-type aquarium air pumps (Mighty III, Fritz Pet Products, Dallas, TX) 
that delivered a combined airflow of 2280 L/hr. This flow was passed through two 
Coming coarse-fritted glass bubblers into the oxygen-scavenging solution for up to 12 hr.
The chemical oxygen-scavenging solution inside the bag consisted o f 0.1 M 
titanium citrate (4.13), which was prepared by dissolving 235 g sodium citrate in one liter 
o f sparged distilled water, followed by addition of 58 g TiCl3. That amount o f titanium 
citrate was a tenfold molar excess over the calculated oxygen load for a 3-hr incubation.
The oxygen load inside the bag consisted of residual air following the final purge, 
the amount that diffused across the plastic membrane, and traces present in the argon. The 
bag had a surface area o f 4000 in2, and a volume of 190 liters when fully inflated. The 
ultrapure argon contained <2ppm oxygen, as specified by the manufacturer. Each 
purge/re-inflation cycle was estimated to remove 90% o f remaining oxygen from the bag, 
or a final residue of 0.0016 moles oxygen after the third purge. Diffusion of oxygen across 
the plastic membrane was 0.0121 moles/hr (Aldrich Technical Service, St. Louis, MO).
Nitroreductase incubations were conducted in 2 mL microcentrifuge tubes, as 
previously described (4.1). Each incubation tube contained 20 fu.L 1 mM NADPH and/or
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NADH, and 20 fjM  1,6-DNP in 20 fj.L dimethyl sulfoxide (DMSO). The amount o f flavin 
was varied between tubes, with individual tubes containing 0, 0.001, 0.01, 0.1, or 1 mM 
FMN. Cytosolic protein contents were likewise varied (0, 0.05, 0.1, or 0.2 mg/mL) 
between tubes in some experiments. Except for incubations conducted in the AtmosBag®, 
an oxygen-scavenging enzyme system was always added to each incubation. This 
consisted o f glucose oxidase (2 units), catalase (15 units), and 75 mM glucose (4.14). 
Each incubation was adjusted to 1 mL final volume with 50 mM potassium phosphate 
buffer. pH 7.4. Incubations were terminated after 1 hr by adding 1 mL argon-sparged 
acetonitrile and centrifuging to precipitate proteins. Each tube was then stored in the dark 
at room temperature or on ice until analyzed. Products were analyzed using HPLC Method 
2  (Chapter 2). Nitroreductase activity was quantitated as the sum o f all nitroreduced 
products in ^mo 1/hr, without regard to the extent to which each product was reduced.
Control experiments were conducted to determine whether a protein contaminant 
accounted for the flavin-dependent reduction. The FMN was assayed for protein using the 
Pierce protein assay, described in Chapter 2. Additionally, incubations were conducted 
using cytosolic fractions or FMN that had been subjected to ultrafiltration (5000 MW 
cutoff), overnight digestion with Proteinase K (2 mg/100 ,uL), or treatment with 40% 
trichloroacetic acid (final concentration 4%), prior to addition of DNP and NADPH as 
described above.
Time-scanning photometry was conducted in a Hitachi U2000 UV/VIS Scanning 
Spectrophotometer (Hitachi Instruments, Inc., Naperville, IL). An incubation mixture was 
prepared under argon by scaling up the quantities of cofactors and oxygen-scavenging
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enzymes used in the individual incubations. This mixture was divided evenly between two 
quartz cuvettes under an argon atmosphere. The cuvettes were capped and pre-incubated 
in the argon chamber for 15 min, then transferred to the spectrophotometer for a baseline 
scan between 250-1100 nm. The sample cuvette was then opened under argon, and 1,6- 
DNP was added, while an equal volume o f DMSO was added to the reference cuvette. 
The cuvettes were re-capped, then scanned at 0 min, and every 20 min thereafter for 220 
min. Scans later than 80 min overlaid each other, and are not shown. Beginning at 20 min 
and every 40 min thereafter, an aliquot was removed from the sample and analyzed for 
products by HPLC.
2-(P-iodophenyl)-3-(/?-nitrophenyl)-5-(phenyl)-2H-tetrazolium chloride (INT), was 
chosen as an alternate electron acceptor for DNP. INT is a water-soluble, reducible dye 
used as an indicator of chemical and biological electron transport (4.16). Equimolar 
amounts o f NADPH and/or FMN were added to a solution o f 90% 50 mM phosphate 
buffer. pH 7.4, containing 7 mg/mL INT. Ten min after the cofactors were added, the 
entire reaction mixture was extracted three times with chloroform to determine whether 
the bright red formazan had formed.
Results
Nitroreductase activity failed to vary with cytosolic protein content over a fourfold 
range. Substantial nitroreduction was observed even in a control incubation containing 
only FMN and no added cytosolic protein [Figure 4.1]. Following this unexpected result, 
individual incubation components were combined with DNP to identify the source of the 
spurious nitroreductase activity.
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As expected, incubations devoid o f both NADPH/NADH and cytosolic protein 
yielded no detectable nitroreduction. Traces o f nitroreduction occurred in blanks 
containing neither cytosolic protein nor FMN, but containing the oxygen-scavenging 
enzymes, glucose and NADPH [see ‘B l.\ Figure 4.1]. Addition o f cytosolic protein to 
this system resulted in some product formation. However, substitution o f FMN for 
cytosolic protein yielded a yet larger increase in reduced DNP products.
In the control experiments, no protein could be detected in the FMN. The effects
Figure 4.1 Nitroreduced product formation in preliminary incubations. All tubes 
contained DNP, NADPH, and oxygen-scavenging enzymes. Cytosolic protein 
concentrations were as specified. FMN (1 m M ) was present in all incubations but ‘Bl.’. 
‘FI.’ and ‘BP did not contain cytosolic protein. Activity at each point is the mean of n=2 
samples.
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o f various treatments on nitroreduction can be seen in Table 4.1. Nitroreduction activity 
could not be reduced or eliminated from a solution o f FMN following incubation with 
bacterial protease, ultrafiltration, or treatment with trichloroacetic acid. In contrast, all of 
these treatments abolished cytosolic nitrporeductase activity.
Table 4.1 Effects of treatments on DNP nitroreduction by cytosolic protein or by 
flavin.
TCA
Treatment 
Proteinase K Filtration
Fraction Tx No Tx Tx No Tx Tx No Tx
Cytosol neg pos neg pos neg pos
FMN pos pos pos pos pos pos
Tx = treated; No Tx = untreated
The possibility that FMN-mediated direct electron transfer was occurring (4.15, 
4.17) was tested by incubating FMN with NADPH and INT [Figure 4.2]. A control 
experiment with NADPH alone yielded trace amounts o f INT reduction over a 30 min
cr
+2e - +H
-2e  '  -H
Figure 4.2 Two-electron reduction o f INT to a formazan precipitate in aqueous 
solution.
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incubation. A second control experiment with FMN alone yielded no detectable 
nitroreduction. When FMN was added to a tube containing both INT and NADPH. the 
solution instantaneously turned a deep orange-brown color, and formed a precipitate 
within ten seconds. Extraction o f the reaction mixture with chloroform yielded a deep 
port-wine colored organic phase consistent with formation of the reduced formazan.
The relationship between FMN concentration and DNP nitroreduction was then 
characterized by measuring nitroreduction activity at lower FMN concentrations. In the 
presence of the oxygen-scavenging enzymes, nitroreduction occurred linearly with the log 
of FMN concentration over the range o f 0.001-0.1 mM [solid lines. Figure 4.3]. When 
titanium citrate-mediated oxygen purging was substituted for the oxygen-scavenging 
enzymes, nitroreduction occurred at an FMN concentration of 0.1 mM. but not at lower
i
12
Oxygen Scavenging
•  Enzymatic
* Chemical
9U
JZ
% 6
0
[FM N ] (Log mM)
Figure 4.3 DNP nitroreduction varied with log [FMN] when oxygen was scavenged 
enzymatically. Titanium citrate-mediated oxygen scavenging may not have been as 
efficient, failing to prevent oxygen-mediated inhibition of nitroreduction at lower 
concentrations o f FMN. Nitroreduction was very slow in incubations containing no FMN, 
yielding barely detectable quantities of products. Each point is the mean ± standard error 
of two determinations.
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FMN concentrations [dashed lines, Figure 4.3]. Nitroreduction was detectable at trace 
levels in incubations containing no added FMN or cytosolic protein.
The reduction of DNP was then followed in a scanning spectrophotometer at 
intervals for 3 hr [Figure 4.4]. The increase in absorbance at 455 nm is consistent with 
accumulation o f oxidized FMN (4.17), whereas the broad peak at longer wavelengths is 
attributable to accumulation of l-amino-6-nitropyrene (A.^ 493 nm), and includes the 
putative l-hydroxylamino-6-nitropyrene (A.max -460-470 nm). Serial HPLC analyses 
confirmed the accumulation of partially reduced products [Figure 4.5], and apparent 
steady-state conditions at 100 min.
Discussion and Conclusions 
Acceleration of nitroreductase activity by reduced FMN was first observed in 
association with the fractionation of tissue nitroreductase activity (4.18). In those
1200
t .0 0 0
400 too600 1000
Wavelength (nm)
Figure 4.4 Electronic absorbance spectra 
o f FMN-mediated nitroreduction reaction 
at times indicated on the tracings. The 
major product o f the reaction was 1 -amino- 
6-nitropyrene, which has a broad 
absorbance peak at 493 nm.
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Figure 4.5 Product profile of FMN-mediated 
nitroreduction o f DNP at times indicated, as 
measured by HPLC. A-hydroxyl-1 -amino-6- 
nitropyrene concentration was estimated 
from the 1-amino-6-nitropyrene standard 
curve.
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experiments, addition of FMN, FAD, or riboflavin to flavin-depleted cell fractions restored 
nitroreductase activity toward p-nitrobenzoic acid. Flavin-dependent increases in 
nitroreduction were subsequently observed by others with nitroimidazoles, nitrobenzene 
derivatives (4.19), azo compounds (4.20) azides (4.21) and nitrofurans (4.17). Thus, the 
current research extends the observation of flavin-dependent DNP nitroreduction to nitro- 
polycyclic aromatic hydrocarbons. There remained the possibility that the enhancement 
o f DNP nitroreduction actually was attributable to some effect of FMN on glucose 
oxidase, a known flavin-containing nitroso-reductase (4.15).
If glucose oxidase were directly responsible for the observed activity, it would be 
expected to catalyze nitroreduction to some extent in a control incubation devoid of FMN 
and cytosolic enzymes. This already had been observed not to occur [’Bl.*. Figure 4.1]. 
but might have been unable to occur if glucose oxidase were significantly flavin-depleted. 
In that situation, repletion of flavin sites might have increased glucose oxidase-dependent 
nitroreductase activity substantially. The incubations under argon using titanium citrate 
scavenging [Figure 4.3] reveal that nitroreduction proceeded without glucose oxidase at 
an FMN concentration of 0.1 mM, which was a tenfold lower FMN concentration than had 
occurred under argon in the absence of glucose oxidase. The absence of a linear response 
at lower FMN concentrations is characteristic of oxygen inhibition, indicating that titanium 
citrate was less efficient than glucose oxidase at oxygen scavenging. Thus, nitroreduction 
proceeded relative to FMN concentration and oxygen content; and the effect o f  glucose 
oxidase on nitroreduction appeared to be limited to its efficient removal of oxygen from 
the system.
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If nitroreduction were driven by an NADPH-FMN redox couple, then the couple 
should be capable o f reducing other substrates. This clearly was observed with INT 
reduction. Furthermore, the electrochemical reduction potential (EZ2 ) o f DNP must be 
more positive than that o f NADPH, the electron donor. This condition has been supported 
by electrochemical experiments, and is reported in Chapter 5.
The hypothesis that the reduced flavin could drive nitroreduction directly (4.18) 
was proven in studies using other substrates in addition to DNPs and INT (4.17, 4.22, 
4.23). The mechanism involved an initial one-electron reduction, with formation of a nitro 
anion radical and a partially oxidized flavin radical, FMNH- (4.19). The radical formed 
even in the presence of known inhibitors of product formation, including molecular oxygen 
and carbon monoxide. This led the authors to conclude that whenever reduced flavin was 
present with a flavin-reducible aromatic nitro group, the nitro anion radical probably was 
being formed. This conclusion has been confirmed in mechanistic studies with a wide 
variety of nitroaromatic medicinal compounds [reviewed in (4.24)]. Therefore, it is 
reasonable to suggest that the same nitroreduction mechanism applies to DNPs.
Research with the nitroimidazoles has revealed that the nitro anion radical can react 
by one-electron transfer reactions with a variety o f competing substrates. 
Disproportionation with another nitro anion radical yields a two-electron reduced product, 
1 -nitro-6-nitrosopyrene: 2 ArN02»~ + H '~  ArNO, + ArN=0 + OH • Nitro-
nitrosopyrenes and other partially reduced intermediates also can accept single electrons 
and undergo disproportionations, effectively culminating in formation of the diamine.
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A side reaction can occur with molecular oxygen (4.25):
ArNO’ + O -  ArNO + O ’ ' rate constant for this reaction is nearly
diffusion limited for nitrobenzoate, whereas the rate o f disproportionation o f the 
nitrobenzoate di-anion radical is six orders o f magnitude slower (4.25). Thus, conversion 
o f a part o f the superoxide to DNA-reactive hydroxyl radicals via Fenton chemistry may 
explain the oxidative DNA damage that reportedly accompanies in vivo exposure to DNPs 
(4.26, 4.27), assuming that the nitro anion radical forms under physiologic conditions.
The side reaction with oxygen also explains oxygen inhibition of nitroreductase 
assays. Oxygen inhibition of nitroreduction (4.25) was apparent in these assays as 
formation of a less completely reduced product series. This is apparent in comparing the 
product profile o f the'FI/ incubation in Figure 4.1 with the products o f the incubation 
used for spectrophotometric time series in Figure 4.5. The former incubation was 
conducted under more stringent anoxic conditions, and yielded primarily pyrene- 1,6- 
diamine. In contrast, the product o f the incubation (identical starting composition) 
periodically exposed to air was l-amino-6-nitropyrene. Another apparent manifestation 
o f oxygen inhibition of nitroreduction activity was a threshold effect. Under room air and 
in the presence of the oxygen-scavenging enzymes, only trace amounts of products were 
formed. Substitution of argon sparging for the enzymes was associated with readily 
quantifiable nitroreduction at I mM FMN concentration, but not at lower FMN 
concentrations. Addition of titanium citrate oxygen scavenging to the system under argon 
lowered the threshold to 0.1 mM; but the glucose oxidase scavenging system appeared to 
remove it completely [Figure 4.3],
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These observations indicate that oxygen interference in nitroreductase assays is not 
trivial, and that great caution should be exercised in interpretation of results obtained 
without strict attention to its exclusion. An example of the problems that accompany lax 
attention to the exclusion of oxygen may be a recent study where erythrocyte 1- 
nitropyrene nitroreductase activity was linked to the presence of added flavin (4.12). It 
was observed that nitroreduction varied with protein concentration, that NADH/FMN 
worked better than NADPH/FMN. and that nitroreduction did not occur in the presence 
of either cofactor without added cell lysate. These results led the author to the conclusion 
that there exists flavin-dependent erythrocyte nitroreductase activity. The problem with 
these studies was that sparging with nitrogen probably was not an effective means of 
reducing oxygen to levels that would not interfere with the assay. If the author had also 
run the same controls under more stringent anoxic conditions, it should have been 
observed that 1-nitropyrene was nitroreduced readily by either set of cofactors in the 
absence of any enzymes, as has been observed in this laboratory (Krautmann, unpublished 
observation).
In light of the studies described herein, the erythrocyte nitroreductase study 
suggests a completely different hypothesis: that any protein may act as a mammalian 
nitroreductase, provided that it has three properties: hydrophobic pockets suitable for 
partitioning of flavin (4.28) and the nitro-substrate; an electron transfer pathway between 
the two, such as the interface between adjacent beta sheets (4.29); and the ability to 
exclude oxygen, and possibly water (4.28), from the route o f electron transfer. This 
definition would be consistent with the observation that all but one of the known
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
74
nitroreductases are flavoenzymes (4.30). It also would suggest that tissue nitroreductase 
activity might best be assayed as flavin content, and it would reopen the question of 
exactly what was induced—enzymes or flavin-associated reducing equivalents—following 
“nitroreductase induction” by 1-nitropyrene (4.8).
Flavin-dependent DNP nitroreduction would have been overlooked in these studies 
if efforts had not been undertaken to maximize the yield o f nitroreduced products. Those 
efforts revealed that without strict attention to exclusion o f air, product formation was 
limited. The well supported conclusion that the nitro anion radical is present whenever 
flavin also is present (4.19,4.24), together with the current studies, lead to a suggestion 
that a control reaction should be run in all nitroreductase assays to demonstrate a linear 
relationship between flavin-dependent nitroreduction with the log o f flavin concentration. 
This control would demonstrate that conditions are adequate for prevention o f oxygen 
inhibition. All subsequent assays of enzyme activity should be done under those conditions 
without addition o f flavin, contrary to common practice (4.3, 4.11,4.21,4.31).
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Chapter 5 
Electrochemical Studies
Introduction
Electrochemical measurements were initiated following demonstration of flavin- 
dependent, non-enzymatic DNP nitroreduction, described in Chapter 4. In those studies, 
it was found that DNP nitroreduction proceeded in the presence o f NADPH and FMN. 
According to the Gibbs Free Energy equation, AG = -r\FAEv , where q is the applied
overpotential, and F  is the Faraday constant, the net change in electrochemical reduction 
potentials (AE,.) for a chemical reaction must be positive in order for the reaction to
= [-0.533 < x < -0.493] V
vs. Sat. C alom el, pH 4.5
vs. S H E
FM NH-- FMN + 2H* + 2e  
DNP + 2e ' » Nitroso-NP + O2'
+219 mV 
-252 mV
DNP + FMNHj -  N itroso-N P + H ,0  -33 mV
Figure 5.1 Normal Hydrogen Scale, showing relative potentials of reference electrodes 
(left side), and Electrochemical Reduction Potentials (EVi) of NADP\ FMN, and DNP 
(5.2, 5.3). Chemicals can be reduced only by substances to their right on the line (more 
negative E,/a). The equations illustrate this: aEv. for the DNP/FMNH-, reaction is negative, 
therefore aG is positive. Therefore, the reaction is energetically unfavorable under the 
conditions shown.
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proceed spontaneously, i.e., Gibbs Free Energy (AG) < 0 (5.1). The published values 
for£,:. o f  DNP (5.2, 5.3) are presented in Figure 5.1. The sample calculation, using an 
E,/; that is adjusted to the Normal Hydrogen Electrode (NHE) scale for the DNP half­
reaction at pH 4.5, yields a negative value for A£*, indicating that AG for the overall 
reaction is positive. Therefore, the FMN/FMNH, redox couple would not be sufficiently 
electronegative to initiate or sustain DNP nitroreduction without some other form of 
energy input.
Measurement of £<; is affected by the solvent (5.4), and by pH, as illustrated for 
DNPs by Djuric (5.2). Thus, the 80% DMSO/acetate buffer. pH 4.5, that was used for 
the electrochemicalmeasurements, must be significantly different from the aqueous 
conditions, pH 7.4, under which the nitroreductase assay is conducted, if indeed the 
reaction is spontaneous. Therefore, experiments were designed to obtain estimates of E,: 
under conditions as close to physiologic as practical.
Materials and Methods
1,6-Dinitropyrene (DNP), l-nitro-6-nkrosopyrene(NONP), l-amino-6-nitropyrene 
(ANP), and pyrene-1,6-diamine (DAP) were synthesized in our laboratory (Chapter 2). 
Cyclic voltammetry (CV) and differential pulse polarography (DPP) were conducted using 
a Computer-Controlled Electroanalysis System (Cypress Systems, Lawrence, KS) in a 
three-electrode cell, with a 1 mm2 platinum disk working electrode, an Ag/AgCl reference 
electrode, and a platinum wire counter electrode. The electrochemical cell, containing 1.4 
mL of 100 mM potassium phosphate buffer, pH 7.4, was sparged for 20 min. Then, 0.2 
mL 1,6-DNP (0.3 mg/mL in DMSO) was added to the buffer, the cell was partially closed,
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and the mixture was maintained under a gentle stream o f argon for the duration o f the 
electrochemical experiments. CV scan rates were varied from 100-2000 mV/sec over a 
range o f+1100 mV to -1300 mV.
Differential Pulse Polarography was performed immediately following cyclic 
voltammetry, using the same configuration and sample solution, except that 100 n L Triton 
X-100 (1% aqueous solution) was added to the analytical solution to suppress artifactual 
currents due to adsorption at the working electrode. Scans were obtained over the range 
o f 0 mV to -1000 mV, using pulse height, 50 mV; pulse width, 50 msec; step height, 2 
mV; cycle period, 100 msec; sample time, 45 msec; current range. 100 aeA; with 500 data 
points collected per analysis.
A preliminary electrolysis o f 1.6-DNP was conducted in a 50-mL boiling flask 
fitted with argon bubbling and venting, a stirring bar, and a platinum wire electrode. A 
gold foil electrode was used as both pseudo-reference and counter-electrode. 1,6-DNP 
(300 /zg) was dissolved in 15 mL DMSO and added to 15 mL 50 mM potassium 
phosphate buffer, pH 7.4, in the electrolysis cell. The solution was stirred and sparged for 
30 minutes, and a potential o f -300 mV was applied using a Dionex potentiostat. Heat 
(final temperature ~46°C) was applied to assist in keeping the DNP dissolved. A color 
change was observed after 3.5 hr. The reaction was continued for 20 hr, after which the 
contents were recovered and analyzed for products.
Electrolyses on platinum electrodes were conducted in a 50-mL round-bottom 
reaction flask. The flask was fitted with a glass pipet that enabled bubbling of the 
electrolysis solution with moisture-saturated argon. The flask headspace vent was placed
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under water to prevent retrograde diffusion
Ag/AgCl
reference
* counter 
electrode
working
electrode
of air into the reaction vessel. The
electrode and counter electrode were of
platinum wire mesh, and potential was
measured against an Ag/AgCl reference. A
magnetic stirrer kept the solution in
constant motion. Access to the Figure 5.2 Mercury electrolysis chamber, 
electrolysate was provided by a glass capillary tube fitted with a 1 mL glass syringe. 
Electrolyses were conducted on -0.6-1 mg 1,6-DNP dissolved in 50 mL of a mixture of 
40% 25 mM phosphate buffer, pH 7.4, and 60% organic solvent, where the organic 
solvent was either dimethyl sulfoxide (DMSO), dimethylformamide (DMF) or dioxane 
(Mallinckrodt Chemicals, Paris, KY).
When a mercury electrode was used, electrolyses were performed in a 20-mL glass 
syringe barrel fitted with a neoprene stopper [Figure 5.2], Glass tubes were passed 
through the stopper to permit argon sparging and venting. The Ag/AgCl reference 
electrode and platinum wire counter electrode also were passed through the stopper. 
Mercury was placed into the bottom of the syringe and allowed to drain out the end o f the 
syringe, and pass through a flexible plastic tube. After the tube was observed to be filled 
with mercury and free of air spaces, the tube was occluded at the distal end using a copper 
wire. The syringe barrel was re-filled with mercury so that the bottom o f the barrel was 
just covered with a pool of mercury. Charge was introduced to the cell through the wire- 
mercury electrode. Electrolyses were conducted over mercury in pure DMSO or in a 
40:60 mixture o f 50 mM phosphate buffer, pH 7.4 and either dioxane or DMF.
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The apparatus always was wrapped in foil to exclude light from the reaction. 
Residual oxygen (nominally <2 ppm from manufacturer) was scavenged from the argon 
by passing the gas into the bottom of a fine-fritted 2 cm * 45 cm glass chromatography 
column filled with a solution of 5% sodium hydrosulfite and 0.05% anthraquinone 
sulfonate fa 100 mL 0.1 M sodium hydroxide (5.5). The purified argon was then directed 
from the top of the column into the electrolysis vessel Product analysis was accomplished 
using HPLC Method 3. described fa Chapter 2.
Results
The results o f preliminary electrochemical experients are presented fa Figure 5.3. 
The cyclic voltammogram (CV) of 1,6-DNP contains a large, partially reversible 
reduction-oxidation system with cathodic and anodic peak currents near -600 mV and -500 
mV, respectively. A second peak current (B) was identified fa a region that had not been 
described fa previous reports of DNP electrochemistry (5.2, 5.3). This peak was so broad 
that its presence was identified clearly only at higher scan rates. Differential pulse 
polarography (DPP) confirmed the presence of peak A, as expected, but did not 
demonstrate a response fa the region corresponding to peak B. The inability to observe 
the peak at B probably was due to addition o f Triton X-100 to suppress adsorption 
artifacts.
A summary o f the results o f some bulk electrolyses of 1,6-DNP is presented fa 
Table 5.1. Nitroreduction occurred fa solvent systems of pure DMSO; 60%DMF fa 25 
mM phosphate, pH 7.4; or 60% dioxane fa phosphate buffer. Most procedures were 
performed at -100 mV vs. Ag/AgCl reference, but nitroreduction was identified chemically
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Figure 5.3 Cyclic voltammograms (CV) and differential pulse polarography (DPP) of 1,6- 
DNP at 100-2000 mV/sec scan rates. The reference line on the CV is the half-wave 
potential (A), which corresponds to the peak on the DPP tracing. A discrepancy is evident 
at the more cathodic potential (B), where a reduction peak current is apparent on the CV, 
but no such peak current can be seen on the DPP. Scans were obtained in 50 mM 
phosphate buffer, pH 7.4, using platinum electrode and counter electrode vs. Ag/AgCI 
reference.
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Table 5.1 Conditions and outcomes of DNP electrolyses.
Conditions Run 1 Run 2 Run 3 Run 4 Run 5
solvent* 50% DMSO 60%Dioxane 60% DMF 60% DMF 60% DMF
electrode Pt Pt Pt Hg Pt
reference Au (pseudo) Ag/AgCl Ag/AgCl Ag/AgCl Ag/AgCl
amtDNP 
(mg/50 mL) 0.6 5.4 0.55 0.38 0.38
Appl. pot. 
(mV) -300
none (resting 
pot.) -100 -100 0
time (hr) 16 16 9 16 6
products** DAP ANP, OTH 82 ng  DAP, 108 ng  ANP
UKN
ANP
UKN
ANP
comments
DNP ppt, 
DMSO
interference w/ 
analysis
spontaneous 
reaction with 
solvent
309 n g  DNP 
in ppt.
DAP std was 
inaccurate
DNP ppt.;
electrode
filming
DNP still sol.
* % solvent in 50 mM phosphate buffer, pH 7.4.
**DAP=pyrene- 1,6-diamine; ANP=l-amino-6-nitropyrene; UKN=unknown product eluting prior to 
DAP (see text); OTH=lesser small peaks.
at potentials as high as 0.0 mV. At 0.0 mV, nitroreduction proceeded more slowly; 
reactions were not conducted at more positive potentials. Spontaneous reactions occurred 
when DNPs were mixed with 60% dioxane and incubated anaerobically in the presence of 
a platinum electrode with no applied potential. This reaction yielded a number of 
products, two of which were identified as pyrene-1,6-diamine and l-amino-6-nitropyrene.
Sample chromatograms from platinum- or mercury-electrode reactions are 
presented in Figure 5.4. Considerable variability was encountered in product composition 
between runs, including products that did not elute with any known authentic standards. 
One such unidentified material, “Ukn” in Figure 5.4, was the predominant product in 
some runs. A diode-array spectrum of this compound was similar to that o f ANP, but its
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retention using HPLC Method 3 was less than that o f  DAP. The material was stable at pH 
12 and in acid above pH 2.5. Addition of concentrated formic acid caused the material to 
decompose.
DNP
0.014-
 420 nm
— 475 nm
I'k n
AN P
0.002-
0 5 1510
O.ltf
Hg
-----420 nm
NO NP
0.12- —  475 nm
0.06- i
-
DAP
A  i A ? p  L L- .
o.oot----------------- : — ,— -— ~~~~ ,
0 5 10 15
Figure 5.4 Sample chromatograms of electrolysates on platinum (Pt) or mercury (Hg), 
showing absorbances at 420 and 475 nm. DNP= 1,6-DNP; NONP=l-nitro-6- 
nitrosopyrene; ANP=l-amino-6-nitropyrene; DAP=pyrene-1,6-diamine; Ukn=unidentified 
component (see text for details); ?=unknown materials. Mercury electro lysates tended to 
foul the reverse-phase column.
A mass of 341 was obtained for the compound by baseline subtraction techniques 
using LC/electrospray ionization with negative ion detection. A tentative structure 
consistent with that mass and with nitroreduction is presented in (Figure 5.5). It should 
be emphasized that this structure, a product o f the reaction o f a DNP intermediate with
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DMF, was under consideration. The
electrochemical experiments were
terminated before the mass and
fragmentation characteristics o f the
unknown compound were established.
Therefore, the proposed structure is not 
definitive, but is presented as a guide for
subsequent investigations. j j  Q
An electrolysis conducted over Figure 5.5 Chemical structure of a possible
product o f electrolysis o f 1,6-DNP in 60% 
mercury at -460 mV vs. Ag/AgCl in DMF: 40% 50 mM phosphate, pH 7.4. The
working and counter electrodes were 
DMSO yielded an intense, forest-green platinum, against a Ag/AgCl reference
electrode.
product that decomposed upon exposure
to water or with storage. HPLC analysis o f the material yielded only DNP and a smail 
amount o f 1,6-ANP, neither o f which is green in color.
Discussion and Conclusions
These electrochemical experiments were undertaken following the observation of 
flavin-dependent DNP nitroreduction in an enzyme assay to further elucidate the redox 
chemistry of DNPs. Ideally, it would have been desirable to replicate the conditions o f the 
enzyme assay in order to obtain E,: under those conditions, but DNP was too insoluble. 
Therefore, various organic solvents were added. It was found that 60% aqueous solutions 
ofdioxane, DMSO or DMF would retain DNP more or less in solution (~1 mg/100 mL). 
The dioxane solution had desirable characteristics from the standpoint o f product analysis,
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but was found to undergo spontaneous reaction with DNP. including nitroreduction. 
DNPs tended to precipitate from solutions o f DMSO during overnight electrolyses. 
Furthermore, analysis o f products in DMSO solutions difficult. DMF mixtures retained 
DNP in solution and did not interfere with analyses, but may have contained impurities that 
reacted with nitroreduced products in the electrochemical cell. However, electrolyses in 
DMF regularly yielded l-amino-6-nitropyrene and pyrene-1,6-diamine, providing clear 
evidence of nitroreduction at the applied potential. Therefore, DMF was used as the 
organic solvent in most o f the electrolyses.
The electrolysis experiments clearly identified nitroreduction at potentials at least 
as high as 0.0 mV vs. Ag/AgCl. This appeared to confirm the existence o f the broad 
cathodic reduction peak current in the cyclic voltammogram [(B) in Figure 5.3], One 
electrolysate yielded large quantities o f DAP and ANP (Run 3, Table 5.1). The sum of 
starting materials and reduction products from this reaction revealed that only about half 
ofthe starting material (850 //g) was recovered from the electrolysate. The low recovery 
was found to be attributable to a partially decomposed DAP standard, which contained 
only about 40% of its original composition. Correction of the DAP value for this amount 
would have adjusted the percent recovery to 75%. Repetition of the experiment yielded 
a mixture of DAP, ANP, and the unknown. Identity o f this compound was hampered by 
the inability to obtain its mass spectrum. Its presence confounded attempts to quantify the 
extent of nitroreduction. Thus, after multiple attempts, product quantitation was 
abandoned.
The thermodynamic considerations discussed in the introduction apparently are 
consistent with flavin-dependent DNP nitroreduction at these potentials. It is still possible,
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but not likely, that nitroreduction occurred as a result o f disproportionation (5.6): 
2ArN02 + 2e ' -  2 ArNO2"  -  /i/W 02 + would mean that
electrolytic product formation was not a measure o f but a manifestation of a reaction
driven by kinetics. Therefore, it cannot be concluded definitively that the electrolyses 
measured E„:. It should be recalled from the differential pulse polarography experiments 
that adsorption artifacts caused massive interference with measurement of currents. This 
suggests that DNP chemistry' may occur by heterogeneous mechanisms, rather than strictly 
in solution phase.
In summary, electrolyses clearly identified DNP nitroreduction at potentials 
significantly more positive than the previously published values for £<.. This tends to 
support a conclusion that the reduction wave at B in Figure 5.3 is a nitroreduction 
current. Identification of nitroreduction at the potentials used in these studies is consistent 
with the observation that DNP nitroreduction can be driven by flavin alone, in the absence 
of enzymatically-coupled energy input.
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Chapter 6 
Protoporphyrin IX-Heme Adducts
Introduction
An adduct o f a DNP metabolite was recently discovered to be bound to the heme 
in peripheral blood hemoglobin (6.1). The adduct formed at a rate o f 0.04% o f the 
administered dose. A similar adduct for l-nitropyrene had a half-life in circulating blood 
of 13.5 da. This led to two hypotheses in the present study that were intended to identify 
facile methods of detecting the heme adducts in wild animals taken from contaminated 
environments.
The first hypothesis was that heme adducts from peripheral blood, and from most 
other cells in the body, could be detected most readily in the bile. The reasoning for this 
hypothesis was that heme adducts probably are eliminated from the body by the same 
pathways as normal heme, i.e., into bile as bilirubin metabolites, or as protoporphyrin IX. 
The 13.5-da half-life of the heme adduct is shorter than the half-life o f normal heme in 
peripheral blood, suggesting that heme adducts constitute a disproportionately large fraction 
of total heme metabolites in bile.
The second hypothesis was that liver tissue per se has a disproportionately elevated 
heme adduct load compared to blood, because of its relatively high nitroreductase activity 
(6.2). An obvious target for such adduct formation might be cytochromes P450, as occurs 
following metabolic activation of xenobiotics o f widely differing structural classes, including 
1-amino-benzotriazole (6.3), griseofulvin (6.4), diethylnitrosamine (6.5), and 
phenylhydrazine (6.6).
90
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Thus, the objective o f this study was to determine whether 1,6-DNP adducts of 
heme or ppIX are sufficiently detectable in liver tissue or bile to be o f use in screening of 
wild rodent populations for exposure to DNPs. To test these hypotheses, rats were 
exposed to a mixture of DNPs containing l,6-dinitro-[4-, 5-, 9-, 10-3H4]-pyrene as a tracer. 
Livers and cecal contents were then analyzed for heme-derived pigments containing bound 
radiolabel. The results o f these studies are presented in this chapter.
Materials and Methods
Pyrene, ppIX, ascorbic acid and butylated hydroxytoluene (BHT) were purchased 
from Sigma Chemical Company, St. Louis MO. SnMPix was purchased from Porphyrin 
Products, Logan, Utah. Acetic and hydrochloric acids, and DMSO were from Mallinckrodt 
Specialty Chemicals. Paris, KY. Trioctanoin was obtained from Pfaltz and Bauer, 
Waterbury, CT. l,6-dinitro-[4-,5-,9-,10-3H]-pyrene (6.7 Ci/mM) was obtained from 
Chemsyn Science, Lenexa, KS. Ammonium hydroxide, nitric acid, methanol and 
acetonitrile were from Curtin-Matheson Scientific, Houston, TX. AIN-93M semipurified 
pelleted diet (6.7) was purchased from ICN Biochemicals, Costa Mesa, CA. DNPs were 
prepared as described in Chapter 2.
A portion of the DNP mixture (75 mg) was added to 12.5 mL trioctanoin, together 
with 63 ^Ci l,6-dinitro-[3H]-pyrene in 1 mL DMSO. After warming and sonication, the 
resulting dosage mixture was counted and found to contain 4.56 jtzCi l,6-dinitro-[3H]- 
pyrene and 5.5 mg DNP mix per mL, or 0.83/uCi /mg.
Twelve male Fischer 344 rats weighing 190-205 g, from Harlan Sprague Dawley, 
Indianapolis, IN, were habituated to the Laboratory Animal facilities and AIN-93M diet for
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5 da. The rats were segregated by weight into 3 groups o f 4 rats. Then each weight group 
was divided randomly among 4 treatment groups. Treatments were assigned to groups at 
random. The control group received saline only for 3 da. Groups 2 and 4 received 85 
mg/kg SnMPix intraperitoneally for 3 and 4 da, respectively. Groups 3 and 4 received 1 
mL of the DNP mixture by gavage on days 1 and 3. Experiments were terminated 48 hr 
following the final dose of the assigned treatment.
At termination, rats were anesthetized with isofluorane. Livers were perfused in situ 
with 1.15% KC1 until free o f blood, then blotted free o f tissue tags and blood clots. Livers 
were then weighed, diced, divided into cryotubes, and frozen immediately in liquid nitrogen. 
Cecal contents were aspirated into a 3 mL syringe through the bowel wall, taking care to 
prevent contamination with blood, then frozen in cryotubes in liquid nitrogen. All samples 
were stored at -70°C until further processing.
Samples were extracted using an adaptation o f a method for isolation o f ppIX from 
feces (6.8). A weighed amount (~lg) o f cecal contents was homogenized in a Wheaton 
tube with a loose-fitting pestle without added buffer. Concentrated HC1 (1.5 mL) was 
added to the homogenate, and the sample was homogenized again until thoroughly mixed 
(~1 min). Then 3 mL each o f distilled water and ether, containing BHT as a preservative, 
were added. The resultant flocculent suspension was rehomogenized to the consistency of 
a uniform, fine suspension/emulsion. This was centrifuged at 1800 x g for 5 min, after 
which cecal pigments could be seen in the acid layer. A 50 piL aliquot of the acid layer was 
filtered through a 0.45/^m syringe filter (Nalge Company, Rochester, NY), and applied 
directly to the HPLC column without neutralization.
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Identical procedures were applied to liver tissue. In contrast to cecal contents, 
pigments partitioned into the ether layer. This occurred in control experiments with ppIX 
alone, and in liver spiked with ppIX. The ether layer was filtered, then evaporated under 
a stream o f  argon. The remaining dark residue was redissolved in 300 /uL 
dimethylformamide containing 1 mM BHT to retard oxidation. A sample (100 (AS) of this 
solution was applied to the HPLC column. Radioactivity was traced in the extraction 
process by obtaining counts on aliquots of whole liver, the organic and aqueous fractions, 
and on unwashed sediments.
A pure ppIX analytical standard was prepared fresh daily in DMF containing 100 
mM BHT. It was found that ppIX would dissolve in this mixture only in the presence of 
ascorbic acid. The pure standard remained stable in this solution for at least 24 hr in the 
dark at room temperature.
HPLC analysis was done as described in Chapter 2. Fractions (1.5 mL) were 
collected as they eluted from the HPLC column using a Buchler fraction collector for 48 
min. These fractions were diluted in 16 mL Hionic-Fluor (Packard Instruments), and 
counted for 30 min in a Packard TriCarb 1900TR Liquid Scintillation Analyzer (Packard 
Instrument Co., Meridien, CT). Radiochromatograms were developed by plotting 
disintegrations per minute (DPM) versus fraction number (time) for each specimen. The 
radiochromatograms were then superimposed upon the absorbance chromatograms to 
evaluate co-elution o f pigments and radioactivity. The resultant elution profiles were 
compared between untreated control, DNP-treated and DNP+SnMPix-treated rats.
Heme oxygenase inhibition was estimated by measuring total serum bilirubin prior 
to the start of the experiment and at termination. Bilirubin measurements were performed
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by the DMA Total Bilirubin assay (DMA, Arlington, TX) as performed on an Olympus 
Reply automated analyzer (Lake Success, NY) at the LSU-SVM Clinical Pathology 
Laboratory.
Results
Heme oxygenase inhibition
Total serum bilirubin levels remained constant (~1 mg/L) throughout the experiment 
in all rats not given SnMPix. Inhibition o f heme oxygenase with SnMPix was associated 
with a decline in total serum bilirubin concentration to levels below the quantitation limit 
o f  the method (0.4 mg/L). Additionally, the livers in SnMPix-treated rats were 25-30% 
smaller than all others, and were discolored with material that was assumed to be SnMPix. 
Partitioning of pigment and label in extraction procedure
DNP+SnMPix-treated liver tissue contained 0.9 nCi /g label, while livers from rats 
treated with DNP alone contained 0.6 nCi /g. This corresponded to 3 and 2.3 nmol [3H]- 
DNP/g tissue, respectively, or approximately 0.04% of the total dose. SnMPix treatment 
did not affect the extent of binding. Following the extraction procedure, half o f the 
radiolabel remained bound with the unwashed solids, and an additional 30% of label stayed 
in the aqueous extract. Thus, less than 20% of label was contained in the ether extract with 
the liver pigments. Evaluation o f cecal contents using similar procedures yielded 
uninterpretable data on radiolabel content because there were differences in food and water 
consumption, which would have affected bile flow and intestinal transit time.
Porphyrins from cecal contents were extracted into the aqueous layer. This was 
consistent with expectations based on the original procedure (6.8), and was verified by 
HPLC. The ether extract of cecal contents was pale yellow-green in color, and could not
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be chromatographed. This was expected, as the original intent o f  the ether extraction was 
to remove substances that would have interfered with analysis of the aqueous phase (6.9). 
No information is available in the published procedures regarding the extraction efficiency 
of this method, but considering the very high extinction coefficient o f  ppIX (180,000), even 
a moderately inefficient procedure should have been evident visually.
The partitioning o f liver pigments into the ether extract contrasted with their 
partitioning from intestinal contents and feces. Chromatograms o f the ether extract from 
liver tissue revealed that the major constituent was ppIX, based on absorbance 
characteristics, retention time, and effects of tissue spiking with authentic ppIX. Extraction 
of an aqueous solution of ppIX with ether following acidification with HC1 also resulted in 
partitioning of ppIX into the organic layer. The absence of HPLC-detectable ppIX in the 
aqueous layer indicated that partitioning of ppIX into the organic phase was complete. 
Evaluation for the presence o f DNP-ppIX adducts
The presence of a large nitroaromatic adduct on a ppIX molecule was expected to 
cause the DNP-ppIX adduct to be eluted at a later time than native ppIX, as occurred in the 
previous method (6.1). The DNP-ppIX peak would be identifiable as co-elution o f pigment 
and radiolabel, assuming no decomposition. In fact, the HPLC profiles that were obtained 
from liver tissues contained a group of broad, poorly resolved pigments, followed shortly 
thereafter by a single large peak at a retention time identical to that o f pure ppIX. 
Radiolabel eluted at essentially background levels throughout (Figure 6.1).
The aqueous fractions of cecal contents contained readily detectable quantities of 
ppIX near 30 min. There were no late-eluting pigments or radiolabelled fractions. In fact,all
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significant radioactivity in the aqueous layer emerged prior to 1 Omin, where DNP and its 
reduced metabolites were eluted (Figure 6.2).
R a d io la b e l Partitioning
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Figure 6.1 HPLC elution profiles o f organic liver extracts from rats treated with DNPs 
alone (A), or with DNPs and SnMPix (B). The dotted line is absorbance, which shows 
ppDC eluting at 30 min; the upper lines are radiochromatograms. Very little radiolabel was 
partitioned into the ether layer with pigments (inset: Radiolabel Partitioning).
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Figure 6.2 Radiochromatograms (solid lines) and uv/vis absorbance o f aqueous cecal 
extracts. DNP metabolites eluted before 10 min; ppIX eluted near 30 min. (A)=DNP + 
SnMPix treatment; (B)=DNP treatment only.
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Discussion and Conclusions
Identification of a DNP adduct bound to a metabolite of heme in bile presented a 
potentially difficult analytical challenge. Normal heme is transformed in a multistep reaction 
sequence to biliverdin (6.10) by heme oxygenase (HO). Biliverdin is reduced to bilirubin 
and transported to the liver, where it is conjugated and secreted into the bile (6.11). It is 
degraded in the intestine to a large number o f products, half of which have not been 
characterized (6.11). If DNP-heme adducts were eliminated similarly, quantitation would 
be difficult or impossible.
However, adduct binding to heme could cause loss of iron from the protoporphyrin 
ring, leaving DNP-ppIX adduct an unsuitable substrate for heme oxygenase (6.12). The
C O O -
Iron-Protoporphyrin IX 
(Heme)
Fe
Steric
hindrance
Heme
oxygenase
Tin-Mesoporphyrin IX 
(Inhibitor)
-No reaction 
-No reaction 
■Biliverdin
Bilirubin
Extensively
degraded
Figure 6.3 Inhibition of heme oxygenase, the rate-controlling enzyme in the multi-step 
conversion o f heme to bilirubin, would cause the adduct to be detectable as a 
protoporphyrin IX derivative. Inhibition could occur if adduct binding caused iron to be 
released from the protoporphyrin ring, or if the adduct sterically hindered enzyme-substrate 
interaction. If neither form o f inhibition occurred, tin mesoporphyrin IX could be used as 
an exogenous inhibitor.
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adduct also could sterically hinder enzymatic degradation. These two inhibitory 
mechanisms raised the possibility that a DNP-heme adduct could be identified in bile as a 
ppIX derivative, rather than a bilirubin metabolite (Figure 6.3). This would present a more 
straightforward analysis. As the extent o f these native inhibitory mechanisms could not be 
known, the experiment was expanded to include a DNP-treated group in which heme 
oxygenase was known to be inhibited with SnMPix (6.13). The observed decline in serum 
bilirubin levels was consistent with inhibition of heme oxygenase in those rats. 
Quantification of total heme oxygenase activity by other methods was not done.
It was considered more practical to attempt to isolate heme adducts from contents 
o f the alimentary tract, rather than by cannulation of the bile duct. Freshly voided feces, 
for example, would be readily available for serial measurements o f ppIX adduct loads. 
Preliminary measures of fecal ppIX revealed substantial variation in fecal ppIX content, and 
that ppIX content declined to negligible levels after 12-18 hr in the presence o f air, as 
reported elsewhere (6.14). Cecal contents were sampled as an alternative, because they 
always would be the first site o f pooling of ingesta following release of bile into the 
alimentary canal. They would therefore be fresh, anaerobic, and subjected to lesser bacterial 
degradation than all subsequent sites in the intestine.
The esterification procedure utilized for identification of DNP-ppIX adducts in 
peripheral blood (6.1) yielded a liquid from feces and cecal contents that fouled the HPLC 
guard column rapidly, despite ultrafiltration. Therefore, an alternative method was chosen 
based on its apparent efficiency at extracting various porphyrins from feces (6.9), and its 
successful adaptation to an automated analysis system (6.8). The method was efficient,
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yielding a clearly pigmented aqueous layer that was free o f interfering substances, and that 
chromatographed well. Identical processing of liver and aqueous solutions of ppIX also 
yielded clear and complete pigment removal, but the ppIX was partitioned into the organic 
phase. The reasons for this difference are not clear, but are probably due to some matrix 
effect, e.g., the presence o f some component of the ingesta that caused the carboxylic acid 
moieties o f the ppIX molecule to remain ionized even at low pH.
A DNP-ppIX adduct would have been stable under the acid conditions o f this 
extraction procedure, based on the finding of El-Bayoumy (6.1) that the DNP-ppIX adduct 
isolated from peripheral blood was stable in concentrated acid and base. Oxidation was a 
problem with pure ppIX, but inclusion of BHT with the standard significantly improved 
stability. BHT was present in the stabilized ether used in the extraction procedure. The 
DNP-ppIX adduct may have been more susceptible to oxidation than native ppIX, but this 
was not described as a problem in the original experiment (6.15). Furthermore, each sample 
was processed and chromatographed individually, in order to minimize exposure to air and 
light.
The DNP-ppIX adduct was assumed to partition into the same layer as the native 
ppIX, but direct evaluation o f the assumption was not possible without an analytical 
standard (Chapter 2). As a partial control, the aqueous (non-pigmented) extracts of liver 
were checked by HPLC for the presence of any potential adducts, and none were found. 
A similar control for the organic extract of cecal contents was not possible because, as 
stated earlier, they could not be resolved into identifiable fractions using this HPLC method.
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If  DNP-ppIX adducts had been found in the organic extracts of liver tissue, then other 
methods would have been developed to evaluate the organic cecal extracts.
Rats in this study received a mixture o f DNPs with a specific activity o f 242 
AiCi/mmol DNPs. The background level o f radioactivity eluted from the column was about 
35 dpm. Using a detection limit o f 135 dpm, and allowing for a sixfold dilution at the time 
o f HPLC injection (i.e., inject 50yuL of 300juL total volume), it can be calculated that the 
DNP-ppIX adduct must have been present at 1 nmol/g liver tissue to be detectable using 
this method. Likewise, a dilution factor o f 15 for cecal contents yields a sensitivity o f 2.5 
nmol/g cecal contents. Based on the results o f standard curves with ppIX, detection o f a 
DNP-ppIX adduct by absorbance should be possible down to levels o f  200 pmoI/L, 
provided that the extinction coefficient and chromatographic resolution o f the DNP-ppIX 
adduct are similar to native ppIX. Assuming that the extraction and analytical methods 
were appropriate, and that the adduct was as stable as the endogenous ppIX, it appears that 
the adduct did not form at levels above these quantities.
It can be estimated from El-Bayoumy’s data (6.1) that administration of a 1 mg/kg 
dose of the radiolabelled DNPs used in the current experiment would have yielded DNP- 
ppIX adducts in peripheral blood corresponding to 188 dpm/g of erythrocytes. The dose 
of DNPs used in this experiment was an order of magnitude higher, but the increased dose 
is offset by the lower ppIX content o f liver, as compared to peripheral blood. Assuming 
that binding of DNPs to ppIX occurs to about half the extent of 1-NP binding (6.1), and 
that the linearity of binding identified by El-Bayoumy extends upward for a sixth order of 
magnitude, detection of binding at the levels reported in the previous study would have
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
101
been at or slightly below the detection limit using this method. However, a ten- or a 
hundredfold increase should have been detectable. Thus, the second hypothesis, that liver 
tissue has a disproportionately elevated heme adduct load compared to blood because of 
its extensive nitroreduction capacity, is disproved.
Whereas the ppIX content o f blood or liver tissue can be assumed to be relatively 
fixed, ppIX content in the gastrointestinal system is a function o f bile flow, which varies 
with appetite and thirst. An additional variable in this study was the short length of 
exposure relative to the 13.5 da half life of the adduct in peripheral blood (6.1). Bacterial 
degradation and chemical decomposition could be significant factors as well. A proper 
evaluation of the first hypothesis would require an experiment designed to account for these 
factors. Therefore, the failure to find increased DNP-ppIX adducts does not support the 
first hypothesis, but does not lend itself to interpretation of the negative results obtained.
Several factors may account for a failure to detect increases in DNP-ppIX adducts 
in liver. Inhibitory and facilitative interactions of DNPs with other chemicals are known to 
exist (6.16). 1,6-DNP was the only labeled isomer in the DNP mixture, and interactions 
between DNP isomers for genotoxicity remain to be studied. A second consideration is 
how well liver-origin ppIX may be protected from reaction with activated DNP 
intermediates: it is possible that there were in fact fewer DNP-ppIX adducts per unit ppIX 
in liver than in blood. The resolution of the assay could have been increased by using a 
higher specific activity in the administered dose, or by scaling up the assay and using a 
greater quantity of tissue. Neither of these would have aided in disproving the original 
hypothesis o f an increased adduct load in liver tissue.
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In conclusion, the results o f these experiments fail to confirm the initial hypotheses 
that there are abundant and readily detectable DNP-ppIX adducts in liver tissue or in cecal 
contents. It is unlikely that ppIX reacts more extensively with activated DNP metabolites 
in liver than in blood cells. However, it is possible that hepatic nitroreductase activity 
actually protects liver heme by accelerating the conversion of DNPs to less reactive 
aminonitropyrenes, thus decreasing effective exposure to the hydroxylamine intermediate 
and its aryl nitrene decomposition product. If this is true, then the assumption on which the 
original hypothesis is founded is fallacious, and non-enzymatic nitroreduction mechanisms 
may be more important to adduct formation.
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Chapter 7
Bone Marrow DNA Analysis of Dinitropyrene-
Treated Rats
Introduction
Exposure of cell cultures to DNPs has yielded lesions consistent with clastogenicity 
in various cell types (7.1. 7.2). Likewise, 1,6-DNP has demonstrated reactivity with the 
spindle apparatus (7.3) in vitro. The cytogenetic damage that occurs in cell cultures 
appears to be attributable to both mechanisms operating concurrently (7.4, 7.5), with 
additional potential for gene mutations from DNA adduct formation (7.6, 7.7). Neither 
the clastogenic nor mitotic spindle poison activity o f DNPs has been measured in vivo.
Evaluation of cytogenetic toxicity has relied on manual counting o f micronuclei 
(7.8-7.10) or chromosome aberrations (7.11, 7.12). The tedious, time-consuming, labor- 
intensive, and statistically weak nature o f these tests has led several investigators to 
develop automated micronucleus tests using computerized image analysis coupled with 
light microscopy (7.13) or flow cytometry (7.14-7.18). One flow cytometric approach has 
utilized DNA analysis to detect a broadening of the G0-G, peak (7.16, 7.19, 7.20). The 
automated methods generally have been found to overcome the limitations o f the manual 
methods.
DNA analysis is capable of resolving intra-species sex differences (7.21) and intra­
individual differences in DNA content between cell types (7.22). It has gained wide 
acceptance as a tool for quantifying aneuploidy in tumor tissues (7.23). DNA analysis has 
been demonstrated capable o f  detecting increased variability o f DNA content o f bone 
marrow cells following acute experimental exposure of rats to cyclophosphamide at 40
104
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mg/kg (7.16). or to triethylenemelamine at 0.50 mg/kg (7.20). Similar changes have been 
found in blood cells obtained from environmental sentinel species exposed to pollutants, 
e.g., cesium-137 in ducks (7.24), complex petrochemical mixtures in wild mice (7.25), and 
benzo[a]pyrene exposure in brown bullheads (Ameiurus nebulosus) (7.26).
The applicability o f  DNA analysis to events at the cellular level from acute 
genotoxicity to measurement o f the tumor cell ploidy suggested that this procedure should 
be utilized more widely in genotoxicity studies at the mechanistic level and as a biomarker 
assay in field exposures. Thus, it was chosen as a method for evaluating the cytogenetic 
toxicity o f  DNPs in the current work. The sensitivity and performance of the DNA 
analysis assay also were evaluated in a positive control exposure using very low doses of 
cyclophosphamide.
Materials and Methods
Com oil, QBSF-58 media, spermine hydrochloride, trypsin, trypsin inhibitor, 
Nonidet P-40, ribonuclease A, propidium iodide, and trisodium citrate, were obtained from 
Sigma Chemical Company, St. Louis, MO. Chicken red blood cells (CRBC) were a gift 
from Dr. R. E. Corstvet at the Department o f Veterinary Science, Louisiana State 
University. Propidium-iodide-compatible, fluorescent polystyrene beads were from Flow 
Cytometry Standards Corporation, San Juan, PR. AIN-93M semipurified pelleted diet 
(7.27) was purchased from ICN Biochemicals, Costa Mesa, CA. A mixture of DNPs 
containing 1-nitropyrene, 7.3%; 1,3-dinitropyrene, 13.7%; 1,6-dinitropyrene, 38.1%; and 
1,8-dinitropyrene, 40.9% was prepared as described in Chapter 2. Silanized test tubes, 
syringes, needles, and Falcon 2054 polystyrene tubes were from Becton-Dickinson, San 
Jose, CA.
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Experimental design and exposures
Forty male Fischer 344 rats were obtained from the breeding colony at the Division 
o f Laboratory Animal Medicine at the LSU School o f Veterinary Medicine. Rats were 
housed in a room maintained at 40-70% relative humidity, 250 C, and a 12-hour light/dark 
cycle. Each rat was weighed and identified, then placed into an individual wire-bottom 
cage with food and water.
Rats were rank-ordered by weight, then placed into ten weight classes. The four 
rats in each weight class were distributed randomly among four dose groups, to yield 10 
rats in each. For logistical reasons, the experiment had to be divided over eight days. This 
was done by dividing the four dose groups (10 rats each) into eight sampling groups (5 
rats each). Each sampling group contained at least one rat from each o f the dose groups; 
otherwise, assignments to sampling groups were at random. Thus, the experiment was a 
randomized incomplete block design.
Preparation of dose
Doses of DNPs that were clearly genotoxic, intermediate, and o f very low 
genotoxicity were chosen based on literature references (7.28-7.30). All formulations 
were prepared immediately before administration by adding DNP to com oil to obtain a 
final concentration of 800 ^g/mL, then making two fortyfold serial dilutions o f that 
suspension in com oil (final concentrations 20 and 0.5 Mg/mL, respectively). A control 
treatment consisted of com oil alone. The resultant suspensions and solutions were 
protected from light by wrapping in aluminum foil.
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Each rat was acclimated to the treatment room and diet for at least three days prior 
to the first treatment. Treatments were administered by gavage at 1 mL/kg body weight 
every other day for 6 doses. Bone marrows were collected for analysis 40 hr past the final 
dose.
Control experiments
A positive flow cytometric control experiment was conducted using 
cyclophosphamide as a clastogen. Dosages o f 0. 0.5 and 5.0 mg/kg cyclophosphamide in 
acacia syrup were administered by gavage every other day for six treatments. The 
experimental design and group assignments were done as in the main experiment. 
However, three dose groups and three sampling groups were used; and the test subjects 
were female, rather than male rats.
A second control was designed to determine the extent of binding of DNPs to bone 
marrow tissues, as measured by uptake o f radio labelled 1,6-DNP from a DNP mixture. 
In this experiment, nine rats were divided into three equal groups. One group was dosed 
with 800 //g/kg (93.8 /uCi/dose) every other day for six doses. The low group was 
administered 20 Mg/kg (2.35 /^Ci/dose), and the controls received com oil alone. All 
treatments were administered by gavage. Following euthanasia by carbon dioxide, one 
femoral bone marrow was removed from each rat and placed directly into 1 mL Soluene 
(Packard Instruments, Meridien, CT). The other marrow was placed in guanidine 
isothiocyanate (see Chapter 2 for DNA isolation methods). After all tissues were 
collected, the samples in Soluene were heated to 50°C until the marrow was dissolved. 
Hionic Fluor (Packard) scintillation cocktail (4 mL) was mixed in, the samples were dark-
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adapted overnight, then counted on a Packard TriCarb 1900 TR Liquid Scintillation 
Counter for 90 min. Counts were corrected for quenching and chemiluminescence. DNA 
was isolated from the marrow samples in guanidine isothiocyanate (Chapter 2), dissolved 
in water and added to Hionic Fluor, and counted. The aqueous and organic extracts from 
DNA isolation wrere counted similarly.
Sample preparation for flow cvtometrv
Bone marrow cells and reagents were prepared according to a published method 
(7.31). Reagents A (trypsin), B (trypsin inhibitor, RNAse), C (stain), and CRBCs (7.32) 
were prepared as a single large batch, then aliquotted and stored frozen at -70°C until use. 
QBSF-58 culture media (2 mL) was aspirated into each of five 3-mL syringes fitted with 
16-ga needles, and these were placed on ice. Each rat was anesthetized with isofluorane, 
and a 0.2 mL blood sample was drawn into 0.5 mL heparinized saline by cardiocentesis, 
for use in a micronucleus assay (7.14, 7.33, 7.34). The femur was then isolated, and both 
ends were trimmed away until no medullary bone spicules remained. The marrow was 
flushed gently into a silanized tube using the QBSF-58 media. The marrow and media 
were poured back into a 3-mL syringe, and gently forced through a 25-ga needle back into 
the test tube. The resulting cell suspension was swirled gently to further disaggregate the 
cells, then allowed to pass through a screen (100 ^m nylon mesh, 47% open, Tetko, 
Briarcliff Manor, NY) into a fresh silanized tube to remove any remaining tissue clumps. 
The cell suspension was stored on ice.
After marrows were collected from all five rats, each cell suspension was counted 
in the Clinical Pathology laboratory using a protocol for counting cell nuclei, on a Baker
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9000 Cell Counter (Biochem Immuno Systems, Allentown, PA). Reagent A (1.44 
mL/tube) was aliquotted to each o f three polystyrene analysis tubes per rat, plus four 
additional tubes for bead and CRBC controls. CRBCs (12 //L) were pipetted to each tube. 
Then, a volume of marrow cell suspension corresponding to 2.8 * 106 cells was transferred 
to each o f three tubes, followed by immediate gentle inversion. Additional QBSF-58 
media was added to to ensure that all tubes contained the same final volume. Ten minutes 
later reagent B (1.1 mL/tube) was added, followed by immediate inversion to mix the 
sample. During the subsequent 10-min incubation, two drops o f a fluorescent polystyrene 
bead internal standard were added to each tube. At the end of that time, reagent C (1.1 
mL/tube) was added, the tube was inverted, placed on ice, and stored in the dark. Flow 
analyses were begun 25-40 minutes following addition of reagent C, and were complete 
within 2 hr.
Sample analysis
Flow cytometry was performed on a FACScan Plus flow cytometer, from Becton 
Dickinson, San Jose, CA. The machine was equipped with a 15 MW argon laser operating 
at 488 run. Photomultiplier tube and gain settings were constant every day. A threshold 
was set on area to include all events. The acquisition rate consistently was 180-200 
events/second using the low flow rate, and 40,000 events were collected per sample. Data 
were acquired in list mode using Lysis software (Becton-Dickinson) on a Hewlett-Packard 
computer, and were transferred to an IBM-compatible 486 computer for analysis.
The raw cytometer data files were analyzed using Modfit 5.2 software (Verity 
Software House). A gate was established on scatterplots of pulse width versus pulse
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Figure 7.1 Gating of raw cytometer data to exclude debris and cell-cell doublets from 
the model. The gate was left wide at G0-G, to avoid excluding singlet events from 
analysis.
integral (7.35) to exclude doublets and debris from the regions o f both internal standards 
and marrow (Figure 7.1). The gate was adjusted during loading of each file to 
accommodate the slight shifts that were observed in cell distribution. The bead, CRBC, 
G0-G, and G2-M populations were modeled as gaussian distributions about the mode of 
fluorescence for each population. S-phase area was modeled as a trapezoid (Figure 7.2). 
Based upon these distributions, preliminary estimates were generated for the mode 
(“mean” or “mean channel”), area, and standard deviation of each peak, as well as total 
S-phase, using an Outside-In algorithm (7.36). The number of events not gated out
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Figure 7.2 Modeling of the DNA histogram. The original histogram is shown as a line, 
beneath which are fitted gaussian functions and a trapezoid, which are used to obtain 
parameter estimates. A second line illustrates the distribution that was estimated in the 
model. The region o f a shoulder peak was cell aggregates that could not be modeled or 
excluded satisfactorily from analysis. The chi-square figures illustrate the difference in 
RCS between using or omitting the gate, the higher value being ungated (dotted lines, 
left). The cell populations, from left to right, are bead and CRBC standards, followed by 
marrow cells in G0-G„ S, and G2-M phases, respectively.
(Total Events), and the Relative Chi-Square (RCS) were used as measures of quality 
assurance (7.37), where Total Events reflected overall quality o f the preparation, and RCS 
indicated the goodness-of-fit o f the modeling procedure (7.37). The parameter estimates 
were then refined using a Marquardt nonlinear least-squares algorithm (7.38).
The refined estimates of the variables for each file were compiled, manipulated, 
summarized and analyzed using SAS Statistical Software (version 6.11, SAS Institute,
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Cary, NC). The endpoints of interest were Total Area, RCS, the G0-G, mean channel and 
coefficient of variation (CV), the relative percentages of cells in each phase o f the cell 
cycle, and the G::G, Mean Channel Ratio. Statistics were computed on these variables 
using General Linear Models procedures. A Bonferroni adjustment was used to control 
for type I error inflation when performing pairwise comparisons of least-square means. 
Residuals were found to be normally distributed by the Shapiro-Wilk statistic.
Results
One rat in the DNP experiment became anorectic, but resumed eating after several 
days. All others tolerated the treatments well. Weight gain, feed intake and feed efficiency 
were similar in all dose levels, and therefore were ignored as covariables.
In the control experiment using radiolabel, whole marrow (-40 mg) contained 
0.0003% of the highest dose. A fortyfold drop in administered dose yielded a twentyfold 
decline in binding. DNA isolated from the marrow contained 3% of total marrow 
radio label at the highest dose, but activity at the lesser dose was below detection limits.
Quality assurance values for the flow cytometry studies are listed in Table 7.1. 
The percentages of the total number o f  events collected were low. The RCS values were 
high, and varied with the exposure and dose.
The cell cycle analysis results for cyclophosphamide and DNPs are presented in 
Table 7.2. No significant shifts occurred in the percentages of cells in each phase of the 
cell cycle with either treatment. The G0-G, and G2-M Mean Channels did not change in 
rats treated with cyclophosphamide. However, a highly significant increase was observed 
in the G0-G| CV (P < 0.0001) following treatment with 5 mg/kg cyclophosphamide. This
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Table 7.1 Quality Assurance values for histogram analyses. Each value is the mean ± 
standard error of 5 samples (cyclophosphamide), or 10 samples (DNP) per dose level.
Criterion
Treatment
Cyclophosphamide DNP mixture
Total Events
Overall 
By Dose
27308±349 (68.25) 
0.0 26098±369 
0.5 28814±506
5.0 27013±698
31268±108 (78.17)
0.0 31838±204
0.5 31631±108
20 31333±265
800 31331±274
5.87±0.09
0.0 5.82±0.24
0.5 5.55±0.12
20 6.05±0.17
800 6.00±0.15
Relative Chi- 
Square
Overall 
By Dose
6.41 ±0.18 
0.0 6.08±0.29 
0.5 6.06±0.27
5.0 7.08±0.30
response was not observed in rats treated with DNPs. However, treatment with DNPs did 
cause a clear increase in the G2-M Mean Channel Fluorescence; and this was expressed 
even more significantly as an increase in the G2:G, Mean Ratio.
Systematic linear variability attributable to the cell preparation method was 
observed in rats treated with DNPs. This was identifiable in plots o f the Mean Channel 
Fluorescence and CV for G0-G, or G2-M versus the corresponding CRBC internal 
standard variables. For this reason, the marrow means and CVs were indexed to the 
CRBC internal standard values for analysis. Residuals for the adjusted variables were 
normally distributed.
Discussion and Conclusions
The measures of quality assurance indicated that deficiencies may have existed in 
both the overall preparation and the modeling of these experiments. It has been reported
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Table 7.2 Cell cycle analysis results in rats treated with cyclophosphamide or DNP 
mixture. Values shown are least square means ± standard errors.
Criterion
Treat
Cyclophosphamide 
Dose LSM±SEM Sig.Diff.+
ment
DNP Mixture 
Dose LSM±SEM Sig.DifT
G0-G, %
0.0 68.066±0.0664 A 
0.5 65.715±0.7153 A 
5.0 66.510±0.5103 A
0.0 66.629±0.0884 A 
0.5 66.632±0.0867 A 
20 67.360±0.0897 A 
800 66.417±0.0867 A
S-phase
%
0.0 26.474±0.1307 A 
0.5 27.999±0.1307 A 
5.0 27.017±0.1411 A
0.0 27.206±0.1047 A 
0.5 27.449±0.1027 A 
20 26.691±0.1063 A 
800 27.736±0.1027 A
G2-M %
0.0 5.4588±0.0902 A 
0.5 6.2860±0.0902 A 
5.0 6.4726±0.0974 A
0.0 6.1648±0.0668 A 
0.5 5.9196±0.0655 A 
20 5.9486±0.0678 A 
800 5.8464±0.0655 A
G0-G,
Mean
0.0 52.955±0.1264 A 
0.5 52.762±0.1264 A 
5.0 53.245±0.1366 A
0.0 2.5290±0.0007* A 
0.5 2.5301±0.0006* A 
20 2.5296±0.0007* A 
800 2.5287±0.0006* A
G„-G, CV
0.0 2.5563±0.0397 A 
0.5 2.6256±0.0397 A 
5.0 2.9104±0.0429
0.0 100.34±0.7285* A 
0.5 98.433±0.7147* A 
20 98.293±0.7397* A 
800 97.799±0.7147* A
Gj-M
Mean
0.0 103.47±0.2513 A 
0.5 103.47±0.2515 A 
5.0 102.91±0.2513 A
0.0 4.9437±0.0023* A 
0.5 4.9559±0.0022* B§ 
20 4.9557±0.0023* B§ 
800 4.9597±0.0022* B§
G2:G,
Ratio
0.0 1.9539±0.0011 A 
0.5 1.9506±0.0011 A 
5.0 1.9434±0.0012 A
0.0 1.9548±0.0009 A 
0.5 1.9588±0.0009 B§ 
20 1.9590±0.0009 BC§ 
800 1.9613±0.0009 C i
Overall experimental error (a=0.05) was controlled with a Bonferroni 
adjustment when making pairwise comparisons. Groups with the same letter 
are not significantly different.
* Values adjusted to CRBC internal standards (Marrow value/CRBC value).
i  p <  0.0001; § p <  0.002;
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that when debris and doublets exceed twenty percent of total events counted (Total 
Events analyzed = less than 80% o f total events acquired), accurate assessment o f S-phase 
is compromised (7.37). The assumptions underlying this recommendation were not given, 
but a further recommendation was to acquire a minimum of 10,000 total events from 
chemically fixed cell preparations, when no internal standards are used. Thus, the 
published guideline may have limited application to the current study, which featured 
acquisition of 40,000 events in unfixed samples containing internal standards. Total 
Events are included in the current database for comparison with future studies.
In these experiments, the average RCS value for DNPs was 5.87. This relatively 
high value (ideal = 1) probably was attributable to the small shoulder peak on the S-phase 
side of G0-G, (Figure 7.2). The shoulder corresponded with a distribution o f events that 
partially overlapped the right side o f the G0-G, distribution on scatter plots (Figure 7.1). 
This distribution probably consisted o f  marrow-bead or marrow-CRBC doublet events. 
A gate sufficiently narrow to exclude these doublets necessarily excluded authentic G0-G, 
events from analysis, directly affecting measures of G0-G, and the total number o f events. 
A wide gate in that region allowed inclusion of nearly all G0-G, events, but required either 
addition of another model component or accepting an increased RCS value. The shoulder 
was too small, broad, and incompletely resolved to be modeled well across all studies. 
Therefore, it was decided to use a moderately open gate at the G0-G, distribution area, to 
include single events while minimizing the doublets. Thus, the RCS values, although 
relatively high, were consistently attributable to the same focus across all samples, and the 
overall results appeared not to be otherwise affected.
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The control experiment with cyclophosphamide was intended to observe a positive 
clastogenic response in the G0-G, population (7.16), while simultaneously evaluating its 
sensitivity. The unadjusted CVs in the cyclophosphamide study were 2.55 ± 0.03% in the 
controls, and 2.91 ± 0.04% at 5 mg/kg cyclophosphamide. Values obtained from similar 
studies include 1.33 ± 0.07% for normal tissues, and 1.62 ± 0.10% in mice exposed to a 
single dose of 30 mg/kg cyclophosphamide (7.16); 2.90-3.84% in normal feral mice (7.25); 
and 3.08% in marrows from normal Sprague-Dawley rats (7.20). Thus, the current results 
compare favorably with reported values for CVs. The positive response to 
cyclophosphamide treatment was highly significant (P < 0.0001), indicating that this 
method is a sensitive assay for clastogenicity. In comparison, 5 mg/kg cyclophosphamide 
was the lowest reported positive dose in a manual bone marrow micronucleus assay (7.10).
The response to DNP exposure was different from the response to 
cyclophosphamide. A highly significant increase was identified in the mean channel 
fluorescence of the G2-M cell fraction. The reasons for this change are not clear. One 
possibility is that each G2-M phase cell contains more DNA. Another possible explanation 
is that the DNA is more open, thus being more accessible to the propidium iodide. O f the 
two, the latter explanation is more easily explained in terms o f biologic mechanisms. A 
more open DNA structure would be expected to occur from poly(ADP)ribosylation (7.39), 
which may be involved in DNA repair processes. It is not possible to conclude that these 
cells underwent cell cycle arrest, as there was no change in the percentage of G2-M cells. 
The complete absence of an effect of DNP on the G0-G, CV was in contrast to the effect 
of cyclophosphamide on that parameter. Assuming that the G0-G, CV is a valid marker
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ofclastogenicity (7.16, 7.20), it is possible to conclude that DNPs are not clastogenic in 
bone marrow cells o f rats following oral exposure.
The absence of detectable clastogenicity is a surprising difference from the effects 
o f  DNPs in cultured cells (7.1), and in freshly isolated human lymphocytes (7.2). One 
factor that may explain the difference in results is the magnitude of exposure at the cellular 
level, where the low solubility of DNPs (Chapter 3) may limit their access to the marrow 
cells. The extent o f uptake of radiolabel in cell cultures could be compared with the 
amount o f label present in marrow in this study. Another useful investigation would be 
to perform a clastogenicity assay on cultured cells with this method, with the objective of 
identifying the threshold dose below which clastogenicity could not be observed with this 
method.
A second explanation for the absence of in vivo clastogenicity is that marrow cells 
are exposed more to DNP metabolites than unmetabolized DNP, particularly N- 
acetylaminonitropyrenes or O-acetyl-AZ-hydroxylaminonitropyrenes. While this exposure 
is associated with formation of DNA adducts, it probably is milder than conditions 
accompanying DNP nitroreduction. The free radicals and the partially nitroreduced 
intermediates that are formed during nitroreduction may directly contribute to DNA 
fragmentation or spindle poisoning, or they may impede cellular responses to DNA 
damage from other processes. The potential also exists for the nitroreduction pathway 
intermediates to contribute to clastogenicity by both mechanisms.
In summary, the DNA analysis procedure was a sensitive assay of clastogenicity. 
The procedure yielded two clearly distinguished responses following exposure o f rats to 
known genotoxic chemicals. Exposure to the clastogen, cyclophosphamide, was followed
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by an observed increase in the G0-G, CV, whereas exposure to DNPs yielded an increased 
staining of the G2-M cell fraction. Both changes were highly significant. It is suspected 
that both responses were manifestations of genotoxicity, but more research is required for 
proper interpretation o f  the observed effects o f DNPs. The absence o f in vivo DNP 
clastogenicity can be explained by lower exposure levels, or by less exposure to the 
reactive intermediates that are formed in the nitroreduction pathway.
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Chapter 8 
Conclusions
The initial objective o f this research was to evaluate biomarkers o f biologically 
relevant exposure to DNPs. Two hypotheses directly addressed that objective. The first 
o f these was whether protoporphyrin IX adducts could be identified in analytically useful 
quantities from liver tissue or a possible porphyrin elimination pathway, i.e., intestinal 
contents. It was concluded that adducts of protoporphyrin IX are not formed in extensive 
quantity in liver tissue, nor are they eliminated in large quantities into the intestinal tract 
in a recognizable form. Therefore, it is unreasonable to expect that protoporphyrin IX 
adducts will be useful biomarkers o f environmental exposure to the levels o f DNPs that 
would be expected to be encountered in the environment.
The second biomarker hypothesis was that DNPs are clastogenic in vivo, as well 
as in vitro in cell cultures. It was unexpectedly found that DNPs were not clastogenic in 
vivo; but that their genotoxicity may have been expressed indirectly as a DNA-repair 
response. The DNA analysis procedure utilized in that assay appeared to be a sensitive 
test o f clastogenicity; it easily detected the consequences o f exposure to a low dose of 
cyclophosphamide. Thus, this test may be useful in future assays o f the subacute 
genotoxic effects of chemicals.
The solubility studies were initiated because of reports in the literature suggesting 
that DNPs persist at the site o f parenteral administration for unusually long periods of 
time. It was found that the water solubility o f DNPs is about 0.035 ppm, and the plasma 
solubility is roughly 20 times higher, or 0.8 ppm. Calculation of log P values using a 
procedure based on the average contribution of chemical substituent groups yielded values
122
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that predicted significantly higher lipid solubility than is suggested by its apparent solubility 
in toluene. This is consistent with the observations in the literature, and supports a 
conclusion that DNPs persist at the site o f parenteral exposure for longer periods than 
might be expected.
The log P values for the reduced DNP intermediates correctly estimated the order 
o f  elution of those compounds from a reversed-phase HPLC column. It was noted in 
experience with the chemical intermediates that solubility in the more polar solvents 
increased substantially with the degree o f nitroreduction. However, these characteristics 
were not quantified, so comparisons between calculated log P values and actual solubilities 
o f the intermediates cannot be undertaken at this time.
If solubility studies were undertaken with the reduced intermediates, they might 
clarify a hypothesis that has been proposed in this laboratory: that a significant portion of 
transport o f DNPs from the site o f  parenteral administration occurs only following 
nitroreduction. It is not known whether this information would be important, but a 
significant clue may be found in the differential pulse polarography experiment. It was 
found in that procedure that extreme current fluctuations occurred without addition of an 
adsorption suppressant. Following suppression, a crest was observed in the region o f -780 
mV. Likewise, electrolysis of 1,6-DNP that was completely dissolved in pure DMSO 
appeared not to proceed on mercury until -470 mV potential vs. Ag/AgCl. Both of these 
values are negative o f the values obtained when adsorption could have been present. It 
should be noted that these experiments were not designed to make this comparison, so 
solvent and electrode differences may explain the observations. However, the feature that
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stands out in both cases is the observation that, with different solvents and electrodes, 
studies o f DNP nitroreduction without adsorption yielded apparent half-wave reduction 
potentials more negative than when adsorption was allowed to occur. The crucial aspect 
o f these observations is that the solution studies do not agree with flavin-dependent 
nitroreduction, which has been identified with DNPs in this work, and is postulated to 
occur in vivo.
Returning to the question of solubility and transport, if DNP nitroreduction takes 
place as a solid, then phagocytosis of DNP particles by immune or reticuloendothelial cells 
might become an important consideration in the expected tumor profile o f DNPs. For 
example, the leukemias and lymphocyte gene mutations that reportedly accompany 
parenteral exposure to DNPs (8.1, 8.2) could be encountered as a result o f phagocytosis 
of DNP particles at the site of administration, followed by transport within a macrophage 
to a regional lymph node for further metabolism.
The straightforward hypothesis that nitroreductase activity would affect expression 
of a biomarker quickly became a major focus of the current research. A key finding of that 
research was the identification of spontaneous flavin-dependent DNP nitroreduction. That 
reaction links the chemistry of DNPs, and probably most other nitro-polycyclic aromatic 
hydrocarbons (NPAH), to the well characterized chemistry o f nitroimidazole and 
nitrofiiran antimicrobials. The spontaneous nitroreduction reaction also pointed out that 
DNPs are more easily reduced than would be predicted from their electrochemical half­
wave reduction potential values. This was verified in electrochemical experiments. A 
comparison of our estimated half-wave reduction potential for DNPs with those of the
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nitroimidazoles suggests that DNPs are very oxidizing relative to those medicinals. This 
implies that a considerable degree of reactivity exists toward such tissue targets as DNA 
and the sulfhydryl groups o f proteins.
Even though NPAH and arylamines share a common aryl nitrenium intermediate 
as an ultimate carcinogen, the one-electron nitroreduction reactions that accompany 
exposure to DNPs would generate a number o f reactive intermediates, any of which could 
act as tumor promoters. Thus, the chemical processes that account for DNP genotoxicity 
may be more involved than the processes accompanying arylamine genotoxicity. The 
nitroso intermediates and free radical byproducts o f the nitroreduction pathway probably 
elicit significant biologic effects that would be concurrent with DNA alkylation. For 
example, pure alkylation o f DNA could lead to cell cycle arrest (8.3). It has been 
suggested that exposure to free radicals leads to the overriding of cell cycle arrest signals 
in order to replace damaged cellular structures or proteins (8.4). Thus, the biological 
consequences of direct exposure to DNPs may be different from the responses expected 
of exposure to the N- or O-acetylated intermediates. This may have contributed to more 
rapid development of tumors at the site o f DNP administration (8.1, 8.2), than at other 
sites where DNA adducts tended to accumulate (8.5, 8.6).
The existence of flavin-dependent nitroreduction in vitro should not be interpreted 
to mean that enzymes are not important determinants of DNP metabolism in vivo. 
However, it does raise important questions about the definition of what constitutes DNP 
nitroreductase activity. A line o f reasoning is offered in the conclusions o f Chapter 4 
suggesting that nitroreductase activity was conferred on erythrocyte proteins simply by 
addition of flavin to the system. The implication is that nitroreductase activity is a generic
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property o f any protein that contains hydrophobic binding sites for DNP and flavin that are 
joined by an electron “tunnel”. The “tunnel” may be nothing more than a hydrogen- 
bonding interface between beta sheets of a protein (8.7). An additional property, exclusion 
o f oxygen, also would be required of a generic nitroreductase. The passive nature o f this 
“catalysis” is supported in a study where the one-electron reduction potentials o f some 
nitroarene pharmaceuticals were highly correlated with the kinetic parameters of the 
enzymes that reduced them (8.8). This study implies that nitroreduction kinetics are 
determined not by the enzyme, but by the nitro substrate. If enzymatic nitroreductase 
activity is that passive, it then becomes reasonable to speculate that the most appropriate 
assay for tissue “nitroreductase” activity might be direct measurement of tissue flavin 
content under strict anaerobic conditions.
In conclusion, the current research was initiated by efforts to identify biomarkers 
o f exposure to DNPs. Although no biomarker was identified, insights were gained into 
the mechanism of DNP nitroreduction that may simplify subsequent efforts to identify 
DNP biomarkers. Specifically, the relatively oxidizing nature o f DNP nitroreduction 
intermediates indicates that biomarkers o f uptake and metabolism most likely will be found 
at the site o f exposure. The mechanistic studies also have suggested several lines of 
research that would be useful in understanding the chemistry of nitroreduction, as well as 
the consequences of exposure to nitro-polycyclic aromatic hydrocarbons.
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Appendix 
Flow Cytometric Bone Marrow 
Micronucleus Test
Introduction
Principles o f flow cvtometrv
In a flow cytometer, cells are isolated for individual study by creating a fine spray 
from the cell suspension. Ideally, each droplet contains a single cell. In order to achieve 
uniform droplet size, the spray nozzle is caused to oscillate at a frequency coinciding with 
the average rate of droplet production.
The measurement o f cell characteristics is achieved by directing a laser beam 
through the cell. Cells with minimal fine internal structure cause light to scatter primarily 
in the forward direction. Those with greater fine structural complexity (ex. fine granules, 
other organelles) cause more side-scattering of light. Forward and side scatter of a sample 
are detected by sensors located 90 and 180 degrees to the path of the incoming light.
Fluorescent dyes excitable by the laser can be utilized as stains for measures of the 
presence of surface or interior cellular components. Nonspecific staining is observed with 
labels such as fluorescein isothiocyanate on proteins; or highly specific labeling can be 
accomplished using fluorescent antibodies. An example o f the latter was the use of anti- 
kinetochore antibodies to measure the presence of kinetochores on chromosomes. In 
some cases, the fluorescent dye is highly specific for a structure. Hoechst 33258 dye binds 
quantitatively to AT-rich regions o f DNA, but nothing else. Thus, it can be used to 
measure cell ploidy. Because the dyes do not all excite and emit fluorescence at the same 
wavelength, the fluorescent dye and the instrument must be chosen concurrently. This is
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to ensure that the laser in the instrument emits at a wavelength that will excite the dye, and 
that the instrument be capable o f detecting its output signal.
It is common to display plots o f forw'ard vs. side scatter in order to select cell 
subsets for further analysis. In rat marrow, platelets are generally the smallest cells, and 
have little internal structure. Therefore, they tend to distribute near the origin and along 
the Y axis (side scatter). Erythrocytes are somewhat larger, and exhibit slightly more side 
scatter; they distribute slightly higher and to the right o f platelets. Reticulocytes do not 
necessarily separate themselves from the erythrocyte series, though they tend to exhibit 
slightly more side scatter. Small round nucleated cells, including lymphocytes and rubricyte 
series generally are found to the right of the erythrocytes. Stem cells and granulocytes are 
found higher and/or to the right in the scatter plot.
Mammalian ervthrocvte micronucleus test
The mammalian erythrocyte micronucleus (EMN) test was introduced in 1970 as 
an indirect method for evaluation of structural or numerical chromosome aberrations 
(A .l). It yields information about cytogenetic toxicity that is closely related to the 
chromosomal aberration (CA) test (A.2), because the micronucleated erythrocyte develops 
from the same types of events that give rise to chromosomal aberrations. However, the 
relative ease of use o f the EMN vs. the CA brought about by the simpler scoring system, 
and the use of a cell type normally devoid of nuclear material have led to wide usage o f the 
EMN test in cytogenotoxicity assays. In fact, the EMN test is considered to be one of the 
most reliable in vivo cytogenetic toxicity tests available today (A.3).
Detection of significant effects in the EMN test still depends on the scoring o f a 
large number of cells. For example, in a recent review (A.4), it was recommended that a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
130
minimum o f 5-8 treatment groups be utilized, and 20,000 reticulocytes scored per 
treatment group. Such an experimental design would enable reliable and reproducible 
detection o f a doubling in EMN frequency attributable to a given treatment. Greater 
sensitivity for detection of the response to a weakly genotoxic agent requires an increase 
in the number of events scored. The magnitude of that increase required for specific levels 
of precision has been reported in a computer simulation of the EMN test (A.5). Assuming 
a goal o f accurately measuring an incidence of EMN of 0.2% (a normal value for 
micronuclei in mouse peripheral blood) with a coefficient o f  variation (CV) of 10%, a 
count o f 50.000 red blood cells would be required. Alternatively, a CV of 2% would 
require scoring of one million red blood cells. The effort involved in attaining such 
precision would be prohibitive using manual microscopic methods for the test. Attainment 
o f such precision demands the development o f automated methods.
Initial efforts to automate the micronucleus test have involved using image analysis 
(A.3, A.6) and flow cytometry (A.7, A.8). The earliest flow cytometric procedures 
demonstrated the ease of scoring increased numbers o f cells for micronuclei, but failed to 
include simultaneous measurement of a reticulocytererythrocyte ratio (A.7, A.9). More 
recent methods have relied on identification o f micronuclei in reticulocytes by staining of 
DNA and cell protein (A.10), or by differential staining o f DNA and RNA (A.11, A.12). 
The latter methods utilized visual inspection o f sorted cells to verify that 90-95% of events 
were in feet micronucleated reticulocytes. However, visual verification of positive events 
after cell sorting is not independent of the preparative and analytical methods, and may 
overlook a method error. The use of glutaraldehyde (A.11) tends to generate substantial 
autofluorescence, thus increasing the background signal from which the weak
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micronucleus signal must be read. The use o f percoll density gradients in this method 
(A.11) also may have been unnecessary because nucleated cells are so easily excluded from 
analysis based on DNA content.
A flow cytometric EMN test using peripheral blood from mice was introduced 
which addresses some of the shortcomings o f other automated procedures. Resolution o f 
micronucleated erythrocytes from all other cell populations was achieved by adapting 
procedures which had been used previously for the study of malaria-infected cells (A. 13), 
which contain an amount of DNA similar to that o f a micronucleus. The method was 
demonstrated to be optimized by comparing actual reproducibility and accuracy of scoring 
against theoretical estimates under ideal conditions (A.5). Following the optimized 
procedures, individual and gender differences in the incidence of micronuclei were easily 
demonstrated, as was a response to methyl methanesulfonate exposure (A. 14). An 
adaptation of this method has been used to follow serial changes in numbers of micronuclei 
in individual mice during exposure to methyl methanesulfonate, cyclophosphamide, and 
colchicine (A. 15).
However, this method had limitations. First, it was not designed to test only 
reticulocytes. Second, it utilized mice rather than rats, which are the species of choice for 
most studies of distribution, metabolism and elimination o f xenobiotics. The use of 
peripheral blood works well in mice, but is likely not to be straightforwardly applied to 
rats, which are known to sequester peripheral micronucleated cells more actively (A. 16). 
This might mean that the rat would be a less sensitive model than the mouse. The 
reticuloendothelial function responsible for sequestration of micronuclei may vary under 
conditions of exposure to some toxicants, thus causing a falsely elevated micronucleus
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count. Despite these considerations, a peripheral blood EMN has been proposed for use 
in rats (A. 17).
A flow method used for counting micronuclei in cell cultures may be adaptable for 
use in rat bone marrow (A. 18). In cell cultures, this procedure has yielded data on the size 
and number o f micronuclei, and has demonstrated resolution of micronuclei as small as 
0.5% o f normal diploid DNA content. The method relies upon simultaneous use of 
Hoechst 33258 and ethidium bromide to generate a dye uptake ratio unique to nuclear 
material, that can be used to discriminate between micronuclei and cellular debris. The 
preservation o f size information by this method may be useful in genotoxicity studies 
(A. 19, A.20). The major limitation of this procedure is the instrument and software 
required for data acquisition and multivariate data analysis.
In the present work, the previously reported studies were used as general guides 
in an effort to establish a flow cytometric micronucleus test in bone marrow using a 
FACScan® flow cytometer. This and similar instruments are more commonly available, 
but limited to use with stains that can be fluorescence-excited at 488 nm. The specific 
objectives of the current research were to establish cell collection and fixation methods; 
to identify an adequate staining method; to resolve the micronucleated cell population from 
other populations on scatterplots; and to determine the comparative responsiveness o f the 
method in a rat bone marrow micronucleus test.
Materials and Methods
Glutaraldehyde, paraformaldehyde, sodium dodecylsulfate, methanol, ethanol, 
propidium iodide, ribonuclease A, and all other reagents came from Sigma Chemical
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Company, St. Louis, MO. 7-Aminoactinomycin D, Pico-Green®, and acridine orange were 
purchased from Molecular Probes, Eugene, OR. Thiazole orange was a gift of Mr. Bob 
Smith-McCollum, Becton Dickinson Instrument Company, San Jose, CA. Antibodies 
were obtained from Accurate, New York, NY. The FACScan® flow cytometer was from 
Becton Dickinson Instrument Company, San Jose, CA.
Sprague-Dawley rats were purchased from the breeder colony in the Division o f 
Laboratory Animal Medicine (DLAM) at the Louisiana State University School of 
Veterinary Medicine. Rats were maintained and housed according to the standard 
AALAC-approved protocols. All handling was in accordance with policies established by 
the Institutional Animal Care and Use committee.
Results
Fractionation of marrow
Initially, it was suspected that other cell populations might interfere with analysis 
o f erythrocyte cell series for micronuclei, unless samples were purified or enriched. 
Therefore, cellulose columns (A.2, A.6) and percoll gradients were utilized for sample 
purification. Passage o f fresh marrow cell suspensions through cellulose columns removed 
platelets and nucleated cells, and the resulting eluate contained only mature erythrocytes 
and reticulocytes. However, the retained cell residues were invariably pink. This was 
interpreted to mean that a portion of the erythrocyte fraction was being lysed or 
marginated on the column. If margination were occuring by mechanisms responsible for 
in vivo reticulocyte margination, a disproportionate share of the marginated cells probably 
would be immature reticulocytes. This would mean that a significant fraction of the
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specific population of interest was being removed from the analytical procedure. 
Therefore, cellulose columns were abandoned.
Gradient centrifugation of peripheral blood using Percoll (A. 11) yielded 5-15-fold 
enrichment for reticulocytes in some fractions. However, partitioning of cell populations 
along the gradient was variable and incomplete. The most immature (macrocytic, 
hypochromic) reticulocytes tended to partition with the platelets and white blood cells, and 
the reticulocyte-rich fraction was not always found in the same density layer. Thus, it was 
concluded that commonly used sample enrichment methods were prone to introducing 
unacceptable artifacts into the proposed method.
Cell fixation
Several criteria were considered important in establishing a cell fixation protocol: 
1) all fractions o f marrow cell suspensions should be preserved intact; 2) preserved cells 
should be stable until analyzed, and retain excellent staining or labeling properties; and 3) 
yield acceptable light-scattering properties.
A number of procedures were evaluated for cell fixation. Frozen alcohols, which 
have been used to fix peripheral mouse erythrocytes (A. 10, A. 13), were unsatisfactory 
because cells clumped badly or formed an immiscible, "powdery" residue on top o f the 
solution upon rehydration. These observations are consistent with literature reviews on 
fixation techniques (A.21).
Treatment of cells with glutaraldehyde and sodium dodecylsulfate (SDS) has been 
used as a fixation technique (A.11). This method induces rapid cell swelling with SDS, 
while fixation of proteins occurs simultaneously with glutaraldehyde. Thus, erythrocytes
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are converted from a biconcave disk shape to a sphere, as are all non-spheroid cells. Plots 
o f  forward- versus side-scattering o f light from cells fixed as described contain tightly 
clustered groups of cells. However, this staining method causes severe background 
auto fluorescence that overwhelmed the fluorescence of a DNA stain. Auto fluorescence 
was attenuated about 10 percent by limiting the duration of exposure of cells to fixative, 
or by treating the fixed cells with sodium borohydride or sodium hydrosulfite, but the 
decrease was too little to be of real benefit.
Paraformaldehyde (PF) (A.22), a slower-acting fixative that imparts lower 
auto fluorescence, also was evaluated under various conditions. Low concentrations 
(<1.5%) of PF yielded the best cell distributions on scatterplots, but did not prevent some 
hemolysis. At concentrations above 2 percent, PF scatterplots were judged to be 
unacceptable, but hemolysis was not observed. It eventually was found that collecting and 
dispersing bone marrows through a 20-gauge needle into 2% paraformaldehyde (PF) 
minimized cell lysis, yielding flow cytometric scatterplots that were acceptable for use in 
further development procedures; and were stable overnight. Further refinement of the 
fixation protocol for uniformity and resolution of cell populations required an acceptable 
staining protocol for micronuclei, and was undertaken at a later stage o f method 
development.
Digestion of RNA and/or DNA
In some stain evaluations, background cross-reactivity of a stain with RNA was 
lowered by predigesting RNA with ribonuclease A. This was done following cell fixation 
by permeabilizing cells with saponin or SDS, then incubating cell suspensions in
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ribonuclease A. This procedure was only partially successful at reducing fluorescence in 
this cell population. Residual background staining following RNAse treatment was 
presumed to be due to ribosomal RNAse or to RNA-protein crosslinking, based on the 
observed resistance to enzymatic degradation.
A second method was evaluated for RNA degradation utilizing 0.1 M hydrochloric 
acid (HC1) to disrupt protein-nucleic acid interactions and degrade RNA (A.23) 
simultaneously. Glutaraldehyde/SDS-fixed cells were treated with 0.1 M HC1 and then 
observed by light microscopy. All cells were spheroid, and stained a homogeneous mild 
basophilic color or a light eosinophilic color. It was inferred from published information 
that the blue staining was free DNA from formerly nucleated cells. The blue staining was 
abolished when cells were treated with deoxyribonuclease I. Notably absent from these 
preparations were any cells having characteristics of reticulocytes. However, acid-treated 
cells were distributed irregularly on flow scatterplots, suggesting that the treatment had 
seriously damaged them. This procedure was considered of possible use if acid damage 
could be controlled and if alcohol-fixation could be substituted for glutaraldehyde. Ideally, 
the procedure would not obliterate reticulocyte antigens, so that they could be labeled with 
fluorescent antibodies. That would allow the enumeration of micronuclei to be confined 
to the reticulocyte pool.
Choice of fluorescent stain
An ideal micronucleus stain would be DNA-specific, and emit intense fluorescence 
only when bound to DNA. Two bright stains that approach these properties are Hoechst 
33258 and DAPI, both of which are excited in the ultraviolet region. Another stain, 7-
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Aminoactinomycin D (AAD), binds specifically to DNA and excites at 488 nm, but does 
not emit an intense fluorescence. AAD is nominally compatible for use with thiazole 
orange (TO), an RNA stain widely used in reticulocyte counts (A.11).
To evaluate nonspecific AAD binding, reticulocyte-rich blood fractions were 
compared to fractions containing only mature erythrocytes. At 1 ppm, AAD stained the 
reticulocyte fraction slightly brighter than mature erythrocytes. This effect disappeared 
at higher dye concentrations. This suggested that a dye concentration of 10-25 ppm would 
eventually be required for detection of micronuclei, and that RNA binding was not a 
significant factor. Subsequent experiments at higher AAD concentrations indicated that 
AAD did not yield a fluorescence intensity necessary to clearly label a micronucleus. 
Therefore, other fluorescent DNA dyes were evaluated.
In contrast to AAD, TO stained both DNA and RNA brightly. RNA and DNA 
were readily quantified following staining at TO concentrations as low as 0.05 ppm. 
However, fluorescence from TO spilled over into the AAD region. This emission overlap 
could not be compensated for electronically, and precluded the use o f TO with AAD for 
quantification of micronuclei in reticulocytes.
It was suggested (personal communication, Dr. Hoffinan, Becton Dickinson) that 
very high concentrations of TO (5-15 ppm) would differentially stain DNA and RNA. To 
evaluate this, white blood cells were stained with TO and scored manually under a 
fluorescent microscope. TO concentrations o f 8 ppm imparted intense orange 
fluorescence to the cytoplasm of cells in the middle of the view field. Cell nuclei and cells 
at the periphery of the viewing field fluoresced green. At 3 ppm, cells and nuclei fluoresced 
green, with some cells exhibiting orange cytoplasmic tags. The observed effects were not
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uniform from slide to slide, and background fluorescence was intense. This staining 
method was judged to be o f no use in a flow cytometric micronucleus assay.
A proprietary dye, Pico-Green® (PG), was selected for evaluation, based on its 
preferential binding to DNA (Molecular Probes catalog supplement). Dilutions o f the 
manufacturer’s stock solutions (original concentration not given) up to 104-fold yielded 
nuclei and micronuclei in fixed cells that were readily visualized under the microscope. 
The same dilution in the flow cytometer enabled good resolution of nucleated from non­
nucleated cells, and linear increases in fluorescence with increasing dye concentration, but 
further dilution was not satisfactory. The concurrent use of SDS and AAD completely 
abolished PG fluorescence. A comparison of staining methods using PG in fixed cells or 
new methylene blue in fresh cells revealed that a disproportionate share o f erythrocytes 
was stained with PG. Although a final conclusion was not reached, it was suspected that 
the high background of nonspecific staining of erythrocytes by PG would impede detection 
o f micronuclei, and that further studies with PG were probably not warranted.
Propidium iodide (PI) was investigated because it was expected to stain 
micronuclei more brightly than AAD. However, its indiscriminate labeling of both DNA 
and RNA would require quantitative removal of RNA. The mixed results of the previously 
described experiments with RNA removal suggested that use of PI should be postponed 
until other approaches were exhausted.
Fluorescent antibodies
The use of fluorescent antibodies was considered as a possible solution to two 
problems. The studies with percoll fractions revealed that some large platelets in bone 
marrow were similar to reticulocytes in size and some staining characteristics. This
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suggested that reticulocyte counts in the flow cytometer could be falsely influenced by 
platelet counts in the absence o f an erythrocyte-specific marker. One such marker, a 
fluorescent antibody to glycophorin A antigen, was available for human and mouse, but 
not rat-specific antigens. A polyclonal antibody against rat erythrocytes cross-reacted with 
other marrow cell types. Adsorption o f the antibody against spleen and thymus cells 
according to the manufacturer’s instructions resulted in failure to purify an erythrocyte- 
specific fraction. After two such adsorptions, the antibody no longer bound any bone 
marrow cell types. Further work on this antibody was discontinued in favor of other 
selection methods or monoclonal antibodies.
A potentially more useful antigen, the CD-71 receptor (CDR), was considered, but 
not evaluated for selecting reticulocytes specifically. The CDR is present in reticulocytes 
at very high early levels, which decline to insignificance over five days (A.24). Thus, any 
anucleate, CDR-positive cell in bone marrow should be a reticulocyte. If a fraction o f these 
cells were depleted of RNA, but retained elevated amounts o f PI or AAD fluorescence, 
they could be classified as micronucleated.
Difficulties in obtaining a clearly satisfactory DNA stain led to consideration of 
fluorescent antibodies as markers for nuclear antigens. A primary antibody derived from 
cell culture supernatant, and specific to nuclei and chromosomes, was reacted against cells 
that had undergone a special lysine-paraformaldehyde-periodate fixation procedure. A 
secondary fluorescent antibody was then used against bound primary antibody. Analysis 
revealed retention of fluorescence in all cells, attributable either to nonspecific binding or 
to incomplete washing o f unbound antibody. The problems in this method, together with 
the extra handling required of a dual-labeling procedure, led to a decision to prepare a
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fluorescein isothiocyanate conjugate o f the primary antibody for further trials. An initial 
attempt at conjugation failed to yield a useful amount o f antibody. Given the relatively 
cumbersome methodology associated with intracellular labeling, and the expense o f 
obtaining a more concentrated antibody, it was decided to exhaust all other possibilities 
with nucleic acid stains before resorting to labeling of intracellular antigens with 
fluorescent antibodies.
Discussion and Conclusions
Efforts were undertaken to establish a micronucleus test for use on a readily 
available clinical flow cytometer equipped with an argon laser capable of fluorescence 
excitation at 488 nm. Previously published procedures were based on the use of more 
sophisticated instruments and ultraviolet-excitable, DNA-specific stains.
Although the original objective o f a micronucleus test was not achieved, this 
research has provided valuable information that should be considered if a similar effort is 
undertaken in the future. The preparation of bone marrow cell suspensions directly in 2% 
paraformaldehyde appeared to abolish marrow cell lysis without inducing excessive 
autofluorescence, as occurred with glutaraldehyde. However, PF exposure appeared to 
cause concentration- or time-dependent declines in quality of cell distributions. This 
suggests that subsequent procedures, such as running samples immediately or continuing 
fixation and storage in ultracold alcohol (A.8), would be appropriate considerations in 
further refinement of the fixation protocol.
Preliminary evaluation of available stains suggests that background 
autofluorescence must be minimized or electronically compensated for AAD to be used. 
The broad autofluorescence signal is observed at nearly constant levels in all channels, so
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it can be measured in one channel, then the signal could be subtracted from the stain-plus- 
autofluorescence channel signaL This must be done on an event-by-event basis, requiring 
either additional circuitry in the flow cytometer or the ability to read and manipulate list 
mode data files. Further adjustments to the fixation protocol may help to reduce 
autofluorescence, but may not be adequate. Background staining attributable to residual 
RNA can not be compensated by this method. Therefore, its usefulness would appear to 
depend on development o f procedures that minimize damage to cells from acid treatment, 
and on identification o f a suitable antibody labeling technique specific to reticulocytes.
Cellulose columns and percoll density gradient centrifugation were not acceptable 
sample preparation methods for rat bone marrow. Percoll gradients were helpful in 
preparing reticulocyte-enriched and depleted erythroid fractions for some qualitative 
studies.
If an RNA-staining method that does not interfere with DNA quantification cannot 
be found, then antibodies to surface antigens may be helpful. In this regard, the CDR 
antigen should be considered, because anucleate, CDR-positive cells should be 
reticulocytes. Polyclonal antibodies such as were used in this study should not be used, 
because of the difficulty o f avoiding removal of desirable antibodies from the mixture when 
undesirable antibodies are removed. Glycophorin A antibodies could be used to confine 
analysis to the erythrocyte pool, if they become available for the rat.
Antibody labeling of nuclear or other intracellular antigens involves loss of cells 
from washing/centrifugation steps, or increased nonspecific intracellular antibody retention 
from omission of washing. It does not appear to merit further work.
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The primary limitation of the current efforts was that no aspect o f the procedure 
could be established as a basis for further optimization. In contrast, all o f the literature 
procedures were developed with stains that are known to be DNA-specific. Further 
procedural refinements were made after establishing methods known to be constant, e.g., 
Tometsko’s (A. 13) refinement o f staining technique using a DNA-specific dye on a 
micronucleus-sized erythrocyte parasite, or Schreiber’s (A. 18) use of DNA staining ratios.
A bone marrow micronucleus test for a FACScan or comparable flow cytometer 
is probably achievable using some combination o f the methods explored in this research. 
The most straightforward method of development would be to refine a method on a dual­
laser flow cytometer using the DNA-specific ultraviolet dye. Then, the optimized cell 
preparation methods could be modified to accommodate use o f a DNA stain that can be 
excited with a 488 nm laser. Only after it has been done under these conditions should it 
be attempted on a clinical-grade machine.
A second, less straightforward approach would be to combine the use o f a 
protozoan erythrocyte parasite in rat peripheral blood, as was done by one group (A. 13) 
with electronic compensation methods. If a staining method can be developed with these 
tools, further refinements would be possible in the cell fixation protocol and selection of 
a reticulocyte-selective marker.
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